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ABSTRACT OF THE DISSERTATION 
 
Brain Enriched microRNAs Open the Neurogenic Potential of Adult Human Fibroblasts  
By 
Daniel G. Abernathy 
 
Doctor of Philosophy in Biology and Biomedical Sciences 
Developmental, Regenerative and Stem Cell Biology 
Washington University in St. Louis, 2017 
Dr. Andrew S. Yoo, Chair 
 
  The seemingly limitless capacities of mammals to sense, respond, and manipulate their 
environments stems from their structurally and functionally diverse nervous systems. 
Establishing these complex behaviors requires the integration of many biological phenomena 
including, morphogenetic gradients, cell-cell signaling, transcriptional networks, cell migration 
and epigenetic gene regulation. As mammalian development progresses, these pathways 
coordinate the production of highly specialized neuronal and glial cells, that connect and 
communicate with another in an even more complex manner. While evolution has shaped a 
multitude of pathways to produce numerous favorable traits, it has also created an intricate 
system vulnerable to disease. The loss of different types of neurons, each responsible for 
specialized biochemical communications within the brain and spinal cord, results in a wide 
 xi 
variety of neurological and neurodegenerative diseases. Unfortunately, many of these diseases 
are uniquely human and cannot be wholly studied in model organisms such as Mus musculus or 
Drosophila melanogaster. Further, their location and absolute necessity precludes isolation 
directly from patients. Fortunately, advances in our understanding of genetic pathways that 
specify neuronal cell fates during development have enabled the directed differentiation of 
embryonic and induced pluripotent stem cells (iPSCs) into specific neuronal subtypes. This 
knowledge has been further leveraged to directly convert (reprogram) non-neuronal somatic cells 
into neurons, bypassing the induction of pluripotency. Specifically, ectopically expressing small 
non-coding microRNAs (miRNAs), miR-9/9* and miR-124 (miR-9/9*-124), with transcription 
factors in human adult fibroblasts is sufficient to generate functionally mature neuronal subtypes. 
These direct conversion modalities may prove invaluable in the study of late-onset 
neurodegenerative diseases, as the original age of human fibroblasts is maintained in converted 
neurons in contrast to the cellular rejuvenation observed in iPSCs. However, little is known 
about the epigenetic and molecular events that accompany direct cell-fate conversion limiting the 
utility of these features. Further, the capacity of miRNAs alone to overcome cell fate barriers has 
largely been unexplored. Within this thesis I provide mechanistic insights into the cell-fate 
pioneering activity of miR-9/9*-124. These results demonstrate that miRNAs induce remodeling 
of chromatin accessibilities, DNA methylation and the transcriptome leading to the generation of 
functionally excitable neurons. Surprisingly, during neuronal reprogramming, miR-9/9*-124 
opens neuronal gene loci embedded in heterochromatic regions while simultaneously repressing 
fibroblast loci, revealing how miRNAs may overcome the cell-fate barrier that exists in human 
fibroblasts. These findings led to the discovery of a miRNA-induced permissive neurogenic 
ground state capable of generating multiple, clinically relevant neuronal subtypes. As such, I 
 xii 
show that the addition of motor neuron factors, ISL1 and LHX3, can function as terminal 
selectors to specify neuronal conversion to a highly enriched population of human spinal cord 
motor neurons. Altogether, the work contained within this thesis identifies miRNA-mediated 
epigenetic remodeling events underlying direct neuronal conversion of human fibroblasts and a 
modular platform capable of generating multiple, clinically relevant neuronal subtypes directly 
from patients. 
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Abstract 
 The specification of multipotent stem cells to defined cell types requires complex 
integrations of genetic pathways. During neurogenesis - the process of generating functional 
neurons from neural progenitor cells - many genetic and epigenetic processes play a critical role 
in regulating genes that control the proliferation and differentiation of neural progenitor cells. 
MicroRNAs (miRNAs) in particular, play an important role upstream of neurodevelopmental 
processes by modulating the expression of genes that alter chromatin states. During neural 
development, miRNAs, particularly brain enriched miR-9/9* and miR-124, regulate 
neurogenesis by targeting many key epigenetic pathways that affect the transcriptional 
accessibility of chromatin regions as well as mRNA processing. Importantly, ectopic expression 
of miR-9/9* and miR-124 in human fibroblasts induces the cells to adopt a neuronal fate. Direct 
conversion of a non-neuronal somatic cell to a functional neuron by brain-enriched miRNAs not 
only emphasizes the essential role of miRNAs in neurogenesis, but also provides new strategies 
for modeling human neurodegenerative diseases and regenerative medicine.  
Key words: neurogenesis, epigenetics, miRNA, reprogramming, REST complex, BAF complex, 
PTBP 
Introduction 
 Development of the mammalian nervous system results from the combinatorial action of 
morphogenetic gradients, cell-cell signaling, transcriptional networks, and cell migration (Götz 
and Huttner, 2005). The output of this intricate regulatory network is a collection of 
interconnected neural cells comprised of glia and neurons. These two cell types can be 
 3 
subdivided further into distinct, highly specialized cells. In addition to developmental programs 
governed by transcription factors, non-coding RNAs facilitate neural fate acquisition (Cao et al., 
2006; Cochella and Hobert, 2012; Pauli et al., 2011; Sun et al., 2013). The most widely 
characterized are small 20-24 nucleotide long microRNAs (miRNAs) that coordinate gene 
expression at the post-transcriptional level (Bartel, 2009; Krol et al., 2010; Pasquinelli, 2012) 
through translational inhibition and mRNA decay (Bartel, 2009; Bazzini et al., 2012; Djuranovic 
et al., 2012; Pasquinelli, 2012). These short stretches of RNA can have marked effects on gene 
networks as a single miRNA can target hundreds of mRNAs (Bernstein et al., 2003; Chi et al., 
2009; Peter, 2010). Furthermore, multiple miRNAs can target a single transcript, dramatically 
increasing the effect on single gene expression (Wu et al., 2010).  These properties enable 
miRNAs to act in both feedforward and feedback loops (reviewed in Ebert and Sharp, 2012) in 
order to establish developmental transitions, cell fate switches, and to refine gene expression.  
 miRNAs have been shown to be an integral part of transcriptional networks that drive 
developmental programs. The importance of miRNAs in many aspects of neural development 
has been reviewed elsewhere (Cao et al., 2006; Cochella and Hobert, 2012; Pauli et al., 2011; 
Sun et al., 2013) and in this issue. Here, we discuss studies that have increased our understanding 
of the activities of miRNAs during neuronal differentiation. We then focus on how genetic 
programs rely on specific miRNAs to reinforce transcriptional programs during neural 
development through feedback and feedforward genetic networks. Identification of genetic 
pathways from neural developmental studies has led to the ability to differentiate neurons from 
embryonic and induced pluripotent stem cells and recently, reprogram non-neuronal cells into 
neurons (reviewed in Morris and Daley, 2013), demonstrating the necessity to understand how 
miRNAs contribute in cell fate decisions during neural development. 
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miRNAs in Development 
 The major path to a mature miRNA begins in the nucleus where RNA polymerase II 
transcribes a primary miRNA transcript (pri-miRNA) that ranges in length, but is generally 
around several hundred base pairs (Lee et al., 2002). The pri-miRNA is processed down to a 60-
100 nucleotide precursor hairpin (pre-miRNA) by Drosha and its cofactor DGCR8 (Bartel, 2009; 
Krol et al., 2010; Pasquinelli, 2012). The intermediate pre-miRNAs are transported into the 
cytoplasm by Exportin 5 where they are cleaved into their mature 19-25 nucleotide form by 
Dicer. Mature miRNAs are loaded into the RNA induced silencing complex (RISC) that, in 
complex with Argonaute (Ago) proteins, typically targets the 3’UTR of mRNAs. This leads to 
either translational repression or mRNA degradation (Bartel, 2009; Bazzini et al., 2012; 
Djuranovic et al., 2012; Pasquinelli, 2012). 
 Initial investigations into the role of miRNAs in development were based on disruption of 
miRNA biogenesis. With the observation that whole mouse embryo Dicer knockouts die at E7.5, 
many groups focused on generating tissue-specific Dicer deletion strains using Cre expression 
(Bernstein et al., 2003). Although the role of specific miRNAs acting through canonical miRNA 
biogenesis cannot be assessed using this strategy, it has revealed interesting facets of miRNAs in 
general and their role during neural development. Notably, proper migration, differentiation, and 
integration of neurons during neurogenesis requires mature miRNAs (Bernstein et al., 2003; 
Kawase-Koga et al., 2009; Makeyev et al., 2007; Volvert et al., 2012). Deleting Dicer in the 
telencephalon during neural development using a FoxG1-Cre line resulted in increased apoptosis 
culminating in a thinner cortical plate (Makeyev et al., 2007). Although there appears to be no 
effect on differentiation, the stereotyped organization of the cortex is disrupted. Further refining 
Dicer ablation in the cortex through the use of a Emx1-Cre driver yields analogous results, but 
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cortical defects appear earlier in development (De Pietri Tonelli et al., 2008). Similarly, deleting 
Dicer in neural progenitors using Nestin-Cre results in increased apoptosis, reduced cortical 
thickness, and increased ventricular volume (Kawase-Koga et al., 2009). 
 FoxG1 and Emx1 are restricted rostrally with Emx1 being the most cortical specific, yet 
in terms of cortical defects, these two Cre-drivers lead to earlier cell death and premature 
neuronal differentiation when compared to the Nestin-Cre driver. This is surprising since Nestin 
is expressed in all neural progenitors. Kawase-Koga and Sun attribute this difference to the 
timing of Dicer deletion, as opposed to cell types.  Delineating the miRNAs responsible for the 
myriad of phenotypes observed in Dicer knockouts has previously been technically unfeasible. 
Now, we are able to examine specific miRNA-target networks at a global level, which has 
facilitated the dissection of miRNA-dependent biological processes. 
Identification of miRNAs enriched in the nervous system  
 Advances in sequencing technology within the past 10 years have greatly increased the 
detectability of specific miRNAs and their targets within a select population of cells. These 
techniques have also shifted several commonly accepted notions of miRNA-mediated regulation 
by demonstrating binding outside the 3’UTR (Lee et al., 2009; Lytle et al., 2007; Ørom et al., 
2008), localization of functioning miRNAs in the nucleus (Buckley et al., 2012; Jeffries et al., 
2011; Khudayberdiev et al., 2013) and lastly bypassing the requirement of the 5’ seed regions 
(Boudreau et al., 2013; Chi et al., 2012; Helwak et al., 2013). Collectively, these studies reveal a 
wider network of target genes and further emphasize the importance of miRNAs in gene 
regulation.  
 6 
 Identifying a collection of miRNAs and their targets has been accomplished primarily 
through target prediction algorithms, crosslinking techniques such as HITS-CLIP and PAR-
CLIP, Ago-HITS-CLIP, and miRNA microarrays (Chi et al., 2009; Hafner et al., 2010; Liu et al., 
2004; Ule et al., 2005). Each of these tools generates hundreds of possible miRNAs and targets 
that must be further validated. Nonetheless, they have revealed changes in miRNA expression as 
the brain develops and have identified many targets that mediate developmental transitions and 
neuronal function, including widely characterized miRNAs, miR-124, miR-9, miR-125, miR-132 
and the let-7 families (Cochella and Hobert, 2012). In addition, these techniques can be applied 
to post-mortem human samples thus enabling the identification and validation miRNAs-mRNA 
interactions within the human brain (Boudreau et al., 2013), allowing comparisons of miRNA 
expression and target recognitions in different species.  
 Boudreau et al. observed a marked difference in the conserved binding sites between 
mouse and human brains (Boudreau et al., 2013). While the authors note the methods used to 
collect and determine the mouse data could have caused this difference, others have 
hypothesized that miRNAs are strong contributors to brain evolution and cognition (Bentwich et 
al., 2005; Hu et al., 2011; Lukiw, 2012) suggesting that the difference between mouse, primate 
and human miRNA expression may have biological meanings.  
 Further refinement of miRNA and target expression analysis through the expression of 
tagged-Ago proteins has enabled miRNA profiling in specific neuronal subtypes. Given the 
potent effects miRNAs have on both neurogenesis and neuronal function, determining the cell 
specific miRNA expression profile within neurons is fundamental to understanding their 
development (Hobert et al., 2010; Sempere et al., 2004).  He et al. characterized the miRNA 
expression profile of five neuronal subtypes within the brain and revealed that glutamatergic, 
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GABAergic, and subclasses of GABAergic neurons within the neocortex and cerebellum, 
respectively, contain distinct but overlapping miRNA expression profiles (He et al., 2012). For 
example, parvalbumin (PV) and somatostatin (SST) expressing GABAergic interneurons overlap 
in miR-124 and miR-9 expression while SST interneurons express miR-187 and miR-551b at a 
level 6-fold higher than PV interneurons. Similarly, Camk2α neurons in the neocortex express 
miR-296 and miR-130b significantly more than Gad2 neurons from the same neuronal 
compartment. It is important to note that over 100 miRNAs were shown to have significant 
differential expression between sub-type comparisons. Interestingly, the authors also observed 
cell-type specific miRNA strand selection from precursors within different neuronal subtypes 
which could provide alternative target selection. So far, the exact role of miRNAs enriched in 
different neuronal subtypes largely remains unknown. 
Function of miRNAs in Early Neural Development  
 Once dorsal ectoderm is specified to become neuroectoderm through BMP and activin 
inhibition and increased Wnt and FGF signaling the central nervous system starts to take shape 
(Stern, 2005). The appearance of the neural plate and formation of the neural folds dorsal to the 
neural plate provides the framework for cell specification. Positional information along rostro-
caudal and dorso-ventral axis of the neural tube has been shown to demarcate future cell fate 
largely through the action of ventral Shh, dorsal BMP and rostro-caudal retinoic acid gradients 
(Jessell, 2000; Stern, 2005). The mechanism that establishes progenitor domains along these axis 
relies on a combinatorial code of morphogenetic gradients and transcription factor networks (for 
review see Jessell, 2000). Many components of the transcriptional and signaling components 
necessary for proper motor neuron pattern formation have been well characterized.  Recent 
evidence suggests that miRNAs also play important roles in regulating the balance between 
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cross-repressive transcription factors within the neural tube. miR-196, miR-17-3p and miR-9 
appear to provide boundary information within the developing spinal cord by refining 
transcription factor networks during motor neuron specification (Asli and Kessel, 2010; Bonev et 
al., 2011; Chen et al., 2011). Interestingly, the biological role of each of these miRNAs during 
neurogenesis differs spatially and temporally along the developing embryos’ axis, suggesting 
that miRNAs can have diverse functions within neurons depending on the milieu of mRNAs they 
encounter. For instance, the combinatorial action of multiple miRNAs can result in stronger gene 
repression leading to greater changes within genetic networks (Wu et al., 2010). Therefore, 
regionally specific miRNAs could coordinate specific programs of neural development. Further 
studies integrating spatially and temporally expressed miRNAs within the nervous system may 
provide insights into the generation of neuronal diversity.  
 Despite different biological outputs, miRNAs both inside and outside of the nervous 
system have been consistently identified has key mediators of both feedforward and feedback 
loops. Here, the repressive activity of miRNAs can act both to activate or inhibit gene 
expression. The redundancy built in these systems is thought to provide robustness to genetic 
networks (Ebert and Sharp, 2012). Below, we review evidence demonstrating the importance of 
miRNAs in enforcing genetic programs through feedforward and feedback loops during cortical 
neuron development, one of the most characterized neural fate programs.  
Feedback Inhibition During Cortical Neurogenesis 
 miR-9, one of the most widely studied neuronal miRNAs participates in a wide variety of 
neuronal differentiation programs (Coolen et al., 2013; Kapsimali et al., 2007). It plays a vital 
role in the differentiation of neural progenitors into post-mitotic neurons by modulating a host of 
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targets (reviewed in Coolen et al., 2013). Within the developing forebrain, the orphan nuclear 
receptor TLX maintains neural stems cells in a proliferative state through activation of Wnt/ß-
catenin and recruitment of histone deacetylases that repress the loci of p21 and PTEN (Qu et al., 
2010; Sun et al., 2007). Suppression of TLX expression in neural stem cells by miR-9 leads to 
decreased proliferation, premature differentiation, and migration toward the cortical plate (Zhao 
et al., 2009). It is thought that during normal development this repressive interaction regulates 
the differentiation of cortical progenitors. Premature differentiation is prevented at least in part, 
by the repression of miR-9 by TLX (Zhao et al., 2009). Others have also shown that processes 
mediated by miR-9 can be attributed to several targets within the cortical progenitor pool 
(Shibata et al., 2011). This negative feedback loop is further strengthened by additional miRNAs 
and targets of miR-9. For example, TLX expression is repressed during neurogenesis by let7b 
(Zhao et al., 2010). miR-137, also highly expressed in the brain, targets LSD1, a co-repressor 
that acts in conjunction with TLX to mediate transcriptional repression (Sun et al., 2011). This 
indicates that the effects of these miRNAs, when expressed together, may have a more dramatic 
phenotype than previously reported. The negative feedback loops present during cortical 
neurogenesis are depicted in Fig1. It is interesting to note that in each of these studies, over-
expression of these miRNAs individually caused remarkably similar phenotypes and the 
expression of a single target often mitigated these effects. In addition, it is unknown if this 
regulatory relationship can be extended outside the cortical compartment. While miR-9 is 
expressed throughout the vertebrate nervous system (Lagos-Quintana et al., 2002), the pool of 
target mRNAs and co-repressive miRNAs could vary between neuronal populations. The ability 
of pan neuronal miRNAs to function differently within different neuronal populations remains an 
open question.  
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 In the case of cortical neuron specification and differentiation, miRNAs clearly integrate 
into known genetic pathways, providing additional information to the developing nervous 
system. However, their relationship to one another and the network as a whole remains unclear. 
If miR-9, miR-137, and let7d have overlapping expression patterns, it is possible that they share 
common targets and their effect on cell fate is more pronounced than previously reported. Such 
synergy has been clearly demonstrated with the brain enriched miRNAs miR-9/9* and miR-124 
(miR-9/9*-124) in chromatin regulation as described below. 
miRNAs and Epigenetic Regulation 
 During development, ATP-dependent chromatin remodeling complexes acquire new 
activities by altering their subunit compositions (Ronan et al., 2013). Differentiation of neural 
progenitors into neurons is accompanied by a switch in the subunit composition of the 
mammalian SWI/SNF (BAF) chromatin remodeling complex.  Specifically, subunits present in 
neural progenitors are exchanged with the neuron specific BAF45B/C, CREST, and BAF53b 
subunits (Lessard et al., 2007; Staahl et al., 2013; Wu et al., 2007). miR-9/9* and miR-124, 
regulate this switch by targeting the 3’ UTR of BAF53a and prolonged expression of BAF53a in 
vivo represses BAF53b expression suggesting that miR-9/9*-124 expression initiates a 
feedforward loop that culminates in the swap of subunits within the BAF complex (Yoo et al., 
2009). The onset of this regulatory cascade is instigated through a negative feedback loop 
between miR-9/9*-124 and the RE1 silencing transcription factor (REST/NRSF) complex 
(Conaco et al., 2006; Packer et al., 2008). 
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Figure. 1 miRNA-dependent negative feedback loops in cortical neurogenesis. As cortical 
progenitors differentiate into cortical neurons the expression of miR-9 and miR-137 is induced 
leading to the direct repression of the orphan nuclear receptor TLX. The expression of miR-9 and 
miR-137 is normally repressed in cortical progenitors by TLX. This negative feedback loop is 
further reinforced by the repression of LSD1, a co-repressor that acts in concert with TLX, by 
miR-137. 
 
 REST/NRSF was initially identified as a neuronal repressor that prevents the expression 
of neuronal genes outside the nervous system (Chong et al., 1995; Schoenherr and Anderson, 
1995). This repressive activity is attained by recruiting other co-repressors such as co-REST, 
SCP1, MeCP2, and histone deacetylases (Andrés et al., 1999; Lunyak, 2002; Roopra et al., 2000; 
Yeo, 2005). As neural progenitors differentiate into post-mitotic neurons, REST/NRSF-mediated 
repression is relieved upon the inhibition of REST/NRSF expression (Ballas et al., 2005). 
Interestingly, REST/NRSF and co-REST have been shown to be regulated by miR-9 and miR-
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9*, respectively (Packer et al., 2008). The sharp contrast in REST/NRSF expression between 
neuronal and non-neuronal cells is maintained through mutual repression between miR-9 and 
REST/NRSF. This negative feedback loop contributes to the neuronal specific expression of 
miR-9/9*-124 as all the active loci of miR-9/9* and miR-124 are occupied by REST/NRSF in 
non-neuronal cells (Conaco et al., 2006). In addition, SCP1, a component of the REST/NRSF 
silencing complex that facilitates neuronal silencing, was shown to be targeted by miR-124 
(Visvanathan et al., 2007).  
 The loss of REST/NRSF-mediated repression and concomitant upregulation of neuron 
specific gene expression is also accompanied by neuron specific splicing events (Li et al., 2007). 
Makayev et al., observed that when miR-124 was overexpressed in two neuroblastoma cell lines 
they adopted a neuron-like morphology and contained neuron-specific alternatively spliced 
transcripts (Makeyev et al., 2007). They showed that the downregulation of the splicing repressor 
PTBP1 by miR-124 leads to neuronal specific splicing events including the production of 
PTBP2, a neuron-specific splicing regulator that is normally excluded from non-neuronal cells 
by PTBP1 (Boutz et al., 2007). Here, the reciprocal expression of PTBP1 and PTBP2 is initiated 
by miR-124 creating both a feedforward and feedback loop. A summary of the miR-9/9*-124 
dependent regulatory circuit is shown in Figure 2. 
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Figure 2. miR-9/9*, miR-124 and REST coordinate neurogenesis through multiple positive 
and negative feedback loops. REST silences many neuronal genes including miR-9/9* and 
miR-124. At the onset of neural differentiation, miR-9/9* and miR-124 are upregulated leading 
to the repression of their targets, REST, BAF53a and PTBP1. REST, co-REST, and SCP1 
repress miR-9/9* and miR-124 which creates a feedback loop allowing for distinct, reciprocal 
expression patterns. BAF53a normally inhibits BAF53b, the relief of this repression by miR-9/9* 
and miR-124 enables BAF53b expression and formation of neuron specific BAF chromatin 
remodeling complex which is important for proper dendritic outgrowth. This feedforward loop is 
distinct from PTBP1’s repression by miR-124. Here, neuron specific splicing is accomplished by 
repression of one splicing repressor, PTBP1, which directly represses the expression of another 
splicing regulator PTBP2. During neurogenesis, the expression of miR-9/9* and miR-124 that 
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are activated at least in part by dismissal of REST binding leads to a cascade of genetic events 
that strongly re-enforces the neurogenic program 
Negative feedback loops are continually being characterized between miRNAs and their 
repressors, and the sum of these feedback loops can have dramatic effects when the balance is 
sharply tipped in one direction. For instance, ectopic expression of miR-9/9*-124 directly 
converts human fibroblasts into post-mitotic neurons (Figure 3) (Yoo et al., 2011).  While neither 
miRNA alone is capable of reprogramming the human fibroblasts, the neuronal conversion can 
be enhanced with the addition of neuronal transcription factors, revealing a synergy between 
multiple miRNAs and pro-neural transcription factors. The observation that miRNAs alone are 
capable of switching cell fate demonstrates their potency in regulating neuronal gene networks. 
Others have also taken advantage of manipulating the genetic circuit involved in neuronal 
specific splicing to achieve neuronal reprogramming (Xue et al., 2013).  
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Figure 3. Neuronal conversion of primary human dermal fibroblasts mediated by miR-
9/9*-124.  Pictures depict (A) human neonatal fibroblasts and (B) converted cells immunostained 
with a pan-neuronal marker, MAP2 (adapted from Yoo et al., 2011).   
 
Asymmetric Cell Division and Neuron Specific miRNA Activity 
 One of the large outstanding questions in mammalian neurogenesis is how asymmetric 
division of neural stem cells is regulated. Recently Schwamborn et al, uncovered that TRIM32, a 
TRIM NHL protein, is asymmetrically inherited during neural progenitor division (Schwamborn 
et al., 2009). The daughter cell that does not receive TRIM32 remains a neural progenitor while 
the daughter inheriting the TRIM32 protein differentiates into a neuron. The mechanism behind 
this differentiation is due to two separate activities performed by TRIM32. As a ubiquitin ligase 
TRIM32 tags c-Myc for degradation. Repression of c-Myc leads to cell cycle exit and further 
participates in neural induction. Secondly, TRIM32 complexes with Ago1 leading to enhanced 
activity of several pro-neural miRNAs. One of these miRNAs, let7a, contributes to neural 
differentiation although not to the extent of TRIM32. Others have also shown let7a has both anti-
proliferative effects and is upregulated during neurogenesis (Peng et al., 2008; Rybak et al., 
2008). The effect(s) of TRIM-32 on other pro-neural miRNAs remains unexplored.  
Conclusion 
 Much like transcription factors, miRNAs can exist in feedback loops with their repressors 
or activators enabling binary switches and signal amplification, respectively. The cumulative 
effect of each regulatory node described thus far results in the vast array of highly specialized 
cells within the nervous system that connect and communicate in an even more complex manner. 
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Our understanding of the development of specific types of neurons has been limited to the 
transcription factors necessary for the development of these populations. The advent of new 
technologies enables mechanistic studies focusing on the function of specific miRNAs during the 
development, and subsequent maintenance of neuronal subtypes. Further understanding of the 
genetic networks that connect each of these pathways within a single cell–type will greatly 
facilitate our understanding of neural development. To date, much progress has been made in 
understanding miRNAs and target interactions in neurogenesis. The results described here are a 
group of select studies that demonstrate both the importance of miRNA-dependent genetic 
networks and the need to connect this accumulated knowledge. 
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Abstract 
 Neuronal microRNAs, miR-9/9* and miR-124 (miR-9/9*-124) direct cell-fate conversion 
of adult human fibroblasts to post-mitotic neurons and with additional transcription factors 
enable the generation of discrete neuronal subtypes. Previously, the molecular events 
underlying the neurogenic switch mediated by microRNAs during neuronal reprogramming were 
unknown. Here, we systematically dissected the neurogenic state induced by miR-9/9*-124 
expression alone. We found that miR-9/9*-124 surprisingly stimulate reconfiguration of 
chromatin accessibility, DNA methylation and mRNA levels, leading to the generation of 
functionally excitable miRNA-induced neurons (miNs) that are yet uncommitted towards a 
particular subtype-lineage. Further subtype identity can be programmed through additional 
transcription factors. As such, we show ISL1 and LHX3 selectively commit conversion to a 
highly homogenous population of human spinal cord motor neurons (Moto-miNs). Taken 
together, our study reveals a modular synergism between microRNAs and transcription factors 
that allows lineage-specific neuronal reprogramming, providing a platform for generating distinct 
subtypes of human neurons. 
INTRODUCTION 
 Understanding genetic pathways that specify neuronal cell fates during development has 
enabled directed differentiation of pluripotent stem cells to specific neuronal subtypes (Perrier et 
al., 2004; Wichterle et al., 2002). This knowledge has been further leveraged to directly convert 
(or reprogram) non-neuronal somatic cells into neurons via ectopic expression of pro-neural 
transcription factors (TFs) or neurogenic miRNAs with TFs (Mertens et al., 2016). These direct 
conversion modalities may prove invaluable in the study of late-onset neurodegenerative 
diseases, as the original age of human fibroblasts is maintained in converted neurons (Huh et 
al., 2016; Mertens et al., 2015) in contrast to the cellular rejuvenation observed in induced 
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pluripotent stem cells (Horvath, 2013; Miller et al., 2013). Interestingly, the miRNA-mediated 
reprogramming approach boasts high conversion efficiency in adult human fibroblasts, which 
may provide unique opportunities in modeling neurological disorders using patient derived 
neurons (Victor et al., 2014). However, despite the advantages of direct reprogramming, little is 
known about the epigenetic and molecular events that accompany direct cell-fate conversion. 
 MiRNAs regulate genetic pathways by binding to their target transcripts and repressing 
their expression (Pasquinelli, 2012). Target specificity is governed largely through short 
sequence complementarity within the 5’ end of a miRNA enabling a single miRNA to target 
hundreds of mRNA transcripts (Boudreau et al., 2014; Chi et al., 2009). Moreover, a single 
mRNA can be targeted by multiple miRNAs, markedly enlarging the effect on single gene 
repression (Wu et al., 2010). The convergence of genetic controls by miRNAs towards a specific 
biological process is exemplified by miR-9/9* and miR-124 miRNAs activated at the onset of 
neurogenesis (Conaco et al., 2006; Makeyev et al., 2007). For example, miR-9* and miR-124 
synergistically initiate subunit switching within BAF chromatin remodeling complexes (Staahl et 
al., 2013; Yoo et al., 2009) while separately repressing the neuronal cell-fate inhibitors REST, 
Co-REST and SCP1 (Packer et al., 2008; Visvanathan et al., 2007). These examples suggest 
that miR-9/9* and miR-124 target components of genetic pathways that antagonize 
neurogenesis to promote a neuronal identity during development.  
Co-expressing miR-9/9* and miR-124 (miR-9/9*-124), with TFs enriched in the cortex 
and striatum directly converts primary adult human fibroblasts to cortical and striatal medium 
spiny neurons, respectively (Victor et al., 2014; Yoo et al., 2011). However, the same TFs 
without miR-9/9*-124 fail to trigger neuronal conversion (Victor et al., 2014; Yoo et al., 2011), 
suggesting that the miRNA-induced neuronal state is permissive to terminal selector TFs which, 
upon determination of a neuronal fate, initiate and advance mature subtype-identities 
(Stefanakis et al., 2015). 
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 Here, we systematically investigated a miRNA-induced neuronal state in adult human 
cells. Longitudinal analyses of the transcriptome, genome-wide DNA-methylation and chromatin 
accessibilities revealed that miR-9/9*-124 induced extensive remodeling of the epigenome, 
including simultaneous activation of a pan-neuronal program and the reconfiguration of 
chromatin accessibilities. These changes precede the emergence of differentially methylated 
genomic regions. Because miR-9/9*-124 also led to the opening of genomic loci for multiple 
subtype-specific genes including established motor neuron markers, we postulated that motor 
neuron-enriched transcription factors would cooperate with miR-9/9*-124 to specify a motor 
neuron lineage. As such, we demonstrate that co-expressing TFs ISL1 and LHX3 along with 
miR-9/9*-124 generated a highly pure population of human spinal cord motor neurons. Taken 
together, these results demonstrate that miR-9/9*-124 opens the neurogenic potential of adult 
human fibroblasts and provides a platform for subtype-specific neuronal conversion of human 
cells. 
RESULTS 
Neuronal Conversion of Human Adult Fibroblasts With miR-9/9*-124 Alone 
 To dissect how miRNAs alone contribute to neuronal conversion, we first tested the 
ability of miR-9/9*-124 to convert primary human fibroblasts collected from multiple adult 
individuals from ages 22 to 68 into microRNAs-induced neurons (miNs). We transduced 
fibroblasts with lentivirus containing a doxycycline (Dox)-inducible promoter driving miR-9/9*-
124 and BCL-XL expression (Victor et al., 2014) (Figures 1A and S1A). At 35 days post-
transduction, we evaluated cell morphology and the expression of neuronal markers MAP2, 
TUBB3 and NEUN by immunocytochemistry (Figure 1B). Strikingly, miR-9/9*-124 alone 
converted 80% of the fibroblasts to neuronal cells displaying complex neurite outgrowth and 
neuronal marker expression (Figures 1B and 1C). The converted cells stained positive for 
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voltage-gated sodium channels SCN1A and Ankyrin G, which localized at axonal initial 
segments with a characteristic polarized staining pattern (Figure 1D). The synaptic vesicle 
marker SV2 displayed defined puncta along neurites, consistent with the adoption of a neuronal 
fate (Figure 1D). 
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Figure 1. Direct Conversion of Young and Old Primary Adult Human Fibroblasts into 
Neurons via miRNA Overexpression. 
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(A) Experimental schema for miR-9/9*-124 mediated direct neuronal conversion. 
(B) Adult human fibroblasts ectopically expressing miR-9/9*-124 for 35 days immunostained for 
the pan-neuronal markers TUBB3, MAP2 and NEUN. Insets represent starting fibroblasts co-
stained as negative controls. Scale bars = 20µm. 
(C) Quantification of TUBB3, MAP2 and NEUN positive cells over total number of cells (DAPI). 
For TUBB3 and MAP2, only cells with processes at least three times the length of the soma 
were counted. For NEUN, only cells with proper nuclear localization were counted. Data are 
represented as mean ± SEM. 22 Yr Female n = 238 cells, 42 Yr Female, n = 100 cells, 56 Yr 
Male n = 171 cells, and 68 Yr Female n = 216. 
(D) Converted neurons display hallmark sodium channel (SCN1A), axonal initial segment 
(ANKG) (left) and synaptic vesicle (SV2) (right) staining patterns. Scale bars = 20µm. 
(E) Representative traces of TTX-sensitive inward and potassium whole-cell currents. 
(F) Repetitive AP waveforms in response to 500 ms current injections recorded from neurons 
converted in monoculture. 
(G) Summary of firing patterns observed in 23 neurons recorded in current-clamp mode (left) 
and representative waveforms within each firing pattern recorded (right). 
See also Figure S1. 
Functional Properties and Stability of MiRNA-induced Neurons  
  To determine if miNs displayed membrane excitability, we performed whole-cell 
recording on miNs without glial co-culture. All cells recorded (23/23 cells) exhibited fast TTX-
sensitive inward currents upon depolarization (Figure 1E, while 19/23 cells fired action 
potentials (APs) during current injections (9 cells fired multiple APs, 10 fired single APs) 
 24 
(Figures 1F and 1G). Similar current (I)-voltage (V) curve relationships were observed between 
cells that fired multiple or single action potentials (Figure S1B). All miNs had a stable 
hyperpolarized resting membrane potential ranging from -52.7 to -84.5 mV with a mean value of 
-69.63 mV ± 2.15 mV (S.E.M.) (Figures S1C and S1D). There was no correlation between 
capacitance and firing patterns suggesting this membrane property is not as an accurate 
measure of neuronal maturation (Figure S1E). Together, this data indicates that miNs exhibit 
the membrane functionality of neurons. 
 The minimum duration of miRNA expression required for neuronal conversion was 
determined by inactivating the doxycycline-inducible promoter at 3-day intervals by Dox removal 
beginning at day 9 until reprogramming day 30 (Figure S1F). Loss of fibroblast identity and gain 
of neuronal identity was assayed by analyzing fibroblast-specific protein (FSP1) and MAP2 
expression, respectively. Surprisingly, we saw a reduction in the number of FSP1-positive cells 
and the appearance of MAP2-positive cells after only 9 days of miRNA expression, however; 
efficient switching of a cell population from FSP1- to MAP2+ required 30 days of miR-9/9*-124 
expression (Figure S1F). These data reveal the non-synchronous process of the neuronal 
conversion and temporal requirements for highly efficient neuronal conversion. The stability of 
miRNA-induced neuronal conversion was determined by following miNs for an additional 30 
days after removing miR-9/9*-124 exposure (Figure S1G, top). The majority of miNs remained 
as post-mitotic neurons (marked by the absence of Ki67, a cell proliferation marker) expressing 
MAP2, TUBB3, NeuN and NCAM, in contrast to non-converted fibroblasts (Figure S1G, left 
panel), indicating that the morphological and protein expression changes that accompany miR-
9/9*-124-mediated conversion of adult human fibroblasts are stable after 30 days of miR-9/9*-
124 expression. 
Transcriptional Profiling of miNs 
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To further explore the miR-9/9*-124-mediated neuronal output, we profiled the 
transcriptome of starting human adult fibroblasts and miNs after 30 days of neuronal conversion 
by RNA-Seq. We identified 2,692 differentially expressed genes (DEGs) in miNs representing 
1,251 up-regulated and 1,441 down-regulated genes in comparison to fibroblasts (log fold 
change ≥ 2 ; adj.P-value <0.01) (Figure 2A). A robust down-regulation of fibroblast-specific 
genes (for instance, S100A4, VIM, FBN1 and, COL13A1) was accompanied an enrichment of 
pan-neuronal genes including MAP2, SCN1A, SNAP25, NRCAM, and NEFM (Figure 2A, 2B top 
two traces). Analysis of top 10 gene ontology (GO) terms revealed that upregulated genes in 
miNs are primarily enriched with terms related to neuronal development and functionality 
(Figure 2C) while down-regulated genes associate with fibroblast functions (Figure 2C). Down-
regulated genes also included key cell-cycle components (data not shown), consistent with the 
previous finding that miR-9/9*-124 expression in human fibroblasts caused rapid cell cycle exit 
without transitioning through a neural stem cell-like state (Yoo et al., 2011). Interestingly, 
neuronal subtype-specific genes such as TH (dopaminergic neurons), GABBR2, GABR1, and 
GAD2 (GABAergic neurons), CHAT (cholinergic neurons), or DARPP-32 (striatal medium spiny 
neurons), were not significantly enriched in miNs (Figure 2B, bottom two traces as examples). 
Overall, our transcriptome analyses show that miR-9/9*-124 induce a neuronal state 
characterized by the loss of fibroblast identity and the presence of a pan-neuronal gene 
expression program without commitment to a particular subtype.  
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Figure 2. Gene Expression Profiling Reveals Pan-Neuronal Identity Induced by miRNAs 
Alone 
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(A) Genome wide expression analysis of miNs and starting fibroblasts by RNA-seq. Plot shows 
the relationship between average gene expression (logCPM) and log fold-change of miNs 
compared to fibroblasts. A selection of pan-neuronal and fibroblast-specific genes are 
highlighted in black text. Blue = fold change <-2 log2 p<.01 (more abundant in fibroblasts),  grey 
= fold change >-2 log2<2 log2 p>.01, and red = fold change>2 log2 p<.01 (more abundant in 
miNs). FDR <.01. 
(B) Representative genome browser snapshots demonstrating increased expression for a pan-
neuronal gene (NEFL), loss of fibroblast marker gene expression (S100A4), and absence of 
neuronal subtype marker gene expression (MNX1, motor neuron marker; DARPP-32, medium 
spiny neuron marker). 
(C) Gene ontology (GO) terms associated with genes upregulated in miNs (red) and GO terms 
associated with genes downregulated in miNs (blue). Right, genes that fall within top GO 
categories listed (top to bottom) in order of lowest to highest p-value. 
(D) Volcano plot representing chromatin remodeling genes differentially expressed between 
fibroblasts and miNs. Blue dot, abs(logFC) > 2 and p < 0.01, red dot, abs(logFC) > 1 and p < 
0.01, grey dot, no significant difference. 
See also Figure S2. 
Transcriptional Changes in Epigenetic Machinery 
 Epigenetic modifications can markedly affect gene expression and developmental 
programs (Cantone and Fisher, 2013). Our gene expression studies showed that when 
compared to fibroblasts, miNs had markedly altered expression of genes involved in DNA 
methylation, histone modifications, chromatin remodeling and chromatin compaction (Figures 
2D and S2). For instance, the TET family of proteins, key mediators of DNA-demethylation (Wu 
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and Zhang, 2011) were upregulated along with the brain-enriched de novo DNA-
methyltransferase DNTM3A (Lister et al., 2013), while DNMT3B (Okano et al., 1999) mRNA 
levels were reduced in miNs compared to fibroblasts (Figures 2D and S2). Transcripts encoding 
histones and histone variants were altered (Figure S2) suggesting that changes in histone 
composition may accompany neuronal conversion of human fibroblasts. Genes encoding 
chromatin remodelers important for neurogenesis like CHD5, CHD7 and components of the 
BAF chromatin remodeling complex were expressed at higher levels in miNs than in fibroblasts 
(Egan et al., 2013; Feng et al., 2013; Lessard et al., 2007) (Figures 2D and S2). Additionally, the 
main DNA topoisomerase 2 family member expressed in miNs is TOP2B, which replaces the 
non-neuronal TOP2A, a switch that has been observed during normal neuronal differentiation 
(Tiwari et al., 2012) (Figures 2D and S2). In sum, dynamic changes and switches within diverse 
epigenetic modifiers coincide with neuronal differentiation and appear to be recapitulated in 
direct neuronal conversion of fibroblasts by miR-9/9*-124.  
Dynamic Regulatory Events During Neuronal Reprogramming 
 Because transcriptome profiling at day 30 only provided a snapshot of the functional 
output of neuronal reprogramming, we explored transcriptome dynamics by profiling 
intermediary timepoints (days 3, 6, 10, and 20) by RNA-seq. The Dynamic Regulatory Events 
Miner (DREM) (Schulz et al., 2012) reports 13 paths of co-regulated, differentially expressed 
genes during the first 20 days of neuronal conversion (Figure 3A). Combining DREM with 
predicted TF-gene binding interactions (Ernst et al., 2010) revealed several potential TFs 
associated with major regulatory events (bifurcations in each path; Figure 3A). Altogether, major 
regulatory events were observed before day 10, suggesting genetic networks are established 
within 10 days of miR-9/9*-124 expression. Thereafter, the directionality of gene expression 
stays the same but transcript levels markedly change. This transcriptional maturation over time 
may explain why the acquisition of functional neuronal characteristics requires 30 days of 
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culture. GO analyses of each path revealed enrichment of neuronal terms in the most 
upregulated path, whereas down-regulated paths were enriched for cell cycle and extracellular 
matrix-related terms (Figure 3B), consistent with results for day 30 transcriptome profiling 
(Figure 2C). The transcriptome switch from a fibroblast to a neuronal program was seen as 
early as day 10 of miR-9/9*-124 expression (Figure 3C), while genes associated with synaptic 
functionality (e.g. HOOK1) are activated at a later time point (day 20, Figure 3C). 
  Finally, there were no significant changes in ASCL1 or SOX2, TFs that have been used 
to reprogram somatic cells into neurons (Niu et al., 2013; Pang et al., 2011). suggesting miR-
9/9*-124-induced neuronal conversion activates a neuronal program through mechanisms 
distinct from those previously reported.  
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Figure 3. Time Series Transcriptome Analysis Reveals Early Dynamic Gene Expression 
Changes Followed by a Stable Transcriptome Switch  
 (A) Dynamic Regulatory Event Miner (DREM) analysis reveals multiple paths of co-regulated 
genes emerge over time (days). 
(B) GO terms enriched in each path (top) and heat maps of genes within the extracellular matrix 
and regulation of synaptic transmission terms (bottom). Z-score normalized RPKM. 
 31 
(C) Representative genome browser snapshots demonstrating the time-dependent loss of 
fibroblast gene expression (top), emergence of pan-neuronal marker gene expression, and 
synaptic component expression (bottom).  
DNA Methylation Profiling of miNs 
 After observing numerous changes in DNA methylation machinery we assessed 
genome-wide DNA methylation at an early (day 10), intermediate (day 20), and late stage (day 
30) of neuronal reprogramming by combining methylated DNA immunoprecipitation sequencing 
(MeDIP-seq) and methylation sensitive restriction enzyme sequencing (MRE-seq; Figure 4A) 
(Zhang et al., 2013). No significant changes in DNA methylation were detected at day 10 
between cells that were exposed to miRNAs and non-treated control (ctrl) cells. In contrast, we 
identified 1,540 differentially methylated regions (DMRs) at day 20 (miN day 20 vs. Ctrl day 20) 
that overlap with DMRs at day 30 (miN day 30 vs. Ctrl day 30; Figures 4B and 4C). The 
difference in DNA methylation at day 30 between treated and control cells was more dramatic 
than changes observed at day 20 with most DNA regions undergoing demethylation. Gene 
ontology (GO) analysis of Mouse Genome Informatics (MGI) expression using the GREAT 
(McLean et al., 2010) tool to characterize the top overlapping DMRs in miNs, enriched only for 
neuronal tissue developmental processes (Figure 4D). Interestingly, these differentially 
methylated regions undergo changes at TS15 in mouse development (equivalent to mouse 
E9/10), which is when miR-9 expression is first detected in developing mouse telencephalon 
(Shibata et al., 2008). Two examples of top DMRs within genes important for neuronal 
development and function are shown in Figure 4E (Gehrke et al., 2010; Vadhvani et al., 2013). 
Nearly 64% of DMRs were located in introns and 28% of DMRs are in intergenic regions (Figure 
4F). Comparison of data from day 30 demethylated and methylated DMRs and RNA-seq 
revealed 882 differentially expressed genes in total. GO analysis of top demethylated DMRs 
associated with upregulated genes (> 2.5 logFC) was enriched for neuronal terms. In contrast, 
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top DMRs associated with down-regulated genes (< 2.5 logFC) did not match GO terms 
involved in neural development (Figure 4G; data not shown). Furthermore, since miR-9/9*-124 
expression quickly induces cell cycle exit, these changes in DNA methylation must necessarily 
occur via active processes, such as those catalyzed by TET and TDG enzymes (Kohli and 
Zhang, 2013), rather than via failure to remethylate DNA after DNA replication. 
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Figure 4. MiR-9/9*-124 Alter DNA Methylation at Neuronal Loci 
(A) Schematic of sample collection during miR-9/9*-124-mediated neuronal reprogramming for 
DNA methylation studies. Human fibroblasts were transduced with virus expressing miR-9/9*-
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124 or a non-specific (NS) control (Ctrl) virus at day 0. Samples were collected at day 10, day 
20, and day 30. 
(B) Biclustering analysis of DMRs. Heatmaps based on MeDIP-seq RPKM (left) and MRE-seq 
RPKM (right) showing overlapping DMRs at days 20 and day 30.  
(C) Quantification of DMRs at multiple q-value cutoffs (q < 5e-2 in red; q < 5e-3 in yellow; q < 
5e-4 in purple) across all time points: miN 10 (miN day 10 vs. Ctrl day 10), miN 20 (miN day 20 
vs. Ctrl day 20), and miN 30 (miN day 30 vs. Ctrl day 30).  
(D) Tissue development enrichment of top overlapping DMRs at day 20 and day 30 show 
neuronal tissue terms at TS15 (~E9/10 in mouse development).  
(E) WashU Epigenome Browser screenshots of two DMRs: FBXO31 (left) and MIRLET7BHG 
(right) loci are shown with MeDIP-seq tracks (red; top), MRE-seq tracks (green; middle), and 
DMR positions (purple; bottom).  
(F) Genomic distribution of differentially methylated and demethylated regions.  
(G) Functional enrichment of top demethylated and upregulated (red; left) or methylated and 
downregulated (blue; right) DMRs overlapping at day 20 and day 30 compared with RNA-seq at 
day 30. 
 
Chromatin Remodeling in miNs  
Extensive expression changes in diverse chromatin remodeling genes during neuronal 
reprogramming (Figures 2D and S2) suggest that miR-9/9*-124 may also alter chromatin 
accessibility. We therefore performed Assay for Transpose-Accessible Chromatin followed by 
high throughput sequencing (ATAC-seq) 10 and 20 days after initiating miR-9/9*-124 induced 
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neuronal conversion. A high correlation between replicates confirmed the reproducibility of our 
analyses (Figure 5A). We obtained 154,406 total peaks across all samples and identified 59,200 
differential peaks (Figure 5B). Of the total peaks detected, 20,712 became more accessible 
(open) and 38,882 peaks became inaccessible (closed). Most differential peaks in miNs at day 
10 overlapped with the peaks at day 20 and the signal intensity of peaks gradually increased or 
decreased during the conversion (Figure 5C), suggesting gradual transition of chromatin 
accessibility during reprogramming (Figure 5C). Interestingly, the ratio of open intragenic to 
distal intergenic regions increased during miR-9/9*-124-mediated conversion (Figure 5D).  
Erasure of Fibroblast Epigenetic Identity and Gain of Neuronal Chromatin Architecture  
 To gain insight into biological relevance of changes in chromatin accessibility after miR-
9/9*-124 expression, we performed gene enrichment analysis on genes with differential ATAC 
signals around the transcription start site ± 2Kb (TSS). We identified 4,915 genes with gradual 
increases and 1,763 genes with gradual decreases in ATAC signals during conversion. Top GO 
terms associated with genes with increased ATAC signals are enriched in neuronal terms 
(Figure 5E), while closed regions were not (Figure S3A). The number of genes in open regions 
associated with neuronal terms gradually increased from day 10 to 20 consistent with our 
transcriptional profiling and coinciding with bona fide neuronal commitment of miNs (Figure 5E). 
Consistent with this hypothesis, chromatin accessibility for fibroblast marker genes like S100A4, 
S100A10, VIM and COL13A1 gradually decreased between 10 and 20 days into neuronal 
conversion. Collectively, our ATAC-seq analyses demonstrate miR-9/9*-124-induced chromatin 
remodeling events are characterized by concurrent closing of fibroblast-related genomic loci and 
opening of neuronal gene loci.  
Next, we examined whether miR-9/9*-124-induced chromatin accessibility correlated 
with changes in mRNA levels. We compared DEGs (logFC > 2 or < -2 adjusted P-value < 0.01) 
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to genes with altered chromatin accessibility around the TSS and identified 501 upregulated and 
184 down-regulated genes that coincide with open and close regions, respectively (Figure 5F). 
GO enrichment analysis revealed that upregulated genes from open regions associate with 
neurogenic terms, while downregulated genes from closed regions are connected with terms 
important for fibroblast function (Figure 5G, see S3E for example tracks). This demonstrates the 
concordant regulation of transcription and chromatin accessibility during reprogramming. 
Interestingly, some opened genomic regions that displayed no changes in gene expression 
contained genes that are uniquely expressed in neuronal subtypes, including those enriched in: 
dopaminergic neuron markers (TH and SLC6A3), serotonergic neuron markers (FEV, LMX1B 
and SLC6A4), GABAergic neuron markers (SLC6A1, SLC32A1, GAD2), striatal medium spiny 
neuron marker (PPP1R1B), glutamatergic neuron markers (GLUL and SLC1A6), and 
cholinergic or motor neuron markers (MNX1, CHAT, and SLC5A7) (Figure S3G for example 
tracks). These results suggest that miR-9/9*-124 poise chromatin to accept additional inputs 
from subtype-specifying determinants without activating subtype-specific programs. In all, the 
chromatin dynamics observed during miRNA mediated neuronal conversion are consistent with 
time-dependent suppression of fibroblast identity concurrent with the opening of neuronal loci 
and activation of pan-neuronal gene expression. 
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Figure 5. MiR-9/9*-124 Globally Changes Chromatin Accessibility 
(A) Two dimensional correlation plot of samples. Pearson’s correlation coefficient: 0.90 for Ctrl 
D10 (or FIB); 0.83 for miNs D10 (D10); 0.90 for miNs D20 (D20).  
(B) Pie chart showing the proportion of differential peaks and total peaks.  Differential peaks 
were obtained by combining all significant peaks (Ctrl D10 vs miNs D10, miNs D10 vs miNs 
D20).  
(C) Heatmaps showing signal intensity in open and close chromatin peaks across all time 
points. All open and closed chromatin regions were ranked according to maximum intensity 
across all samples.  
(D) The genomic distribution of open and closed chromatin regions.  
(E) Comparison of GO terms for genes with open chromatin regions at promoters in miNs at day 
10 and 20, but closed chromatin regions in fibroblasts. 
(F) Heatmaps showing gene expression levels for DEGs positively correlated with ATAC-seq 
signal intensity in their promoter regions. Signal intensity is based on normalized counts per 
million (CPM) values.  
(G) Top GO terms associated with DEGs which correlate with ATAC-seq signal intensity in 
promoter regions.  
(H) Heatmaps showing signal intensity in the open (accessible) and closed (inaccessible) 
chromatin regions that overlapped with histone-marked regions of fibroblasts.  
 I) Integrated genomics viewer (IGV) screenshots showing two different examples of ATAC-seq 
and RNA-seq integration. An example of ATAC-seq and RNA-seq peaks within a pan-neuronal 
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gene: MAP2 (left) and an example of ATAC-seq peaks within a subtype-specific locus without 
gene expression changes: MNX1 (right). 
See also Figures S3 and S4. 
MicroRNA-induced Chromatin Remodeling at Heterochromatin Regions in Fibroblasts 
 To gain a more complete understanding of the epigenetic architecture within opened and 
closed chromatin sites we examined the relationship of these regions to pre-existing histone 
marks present in fibroblasts. We hypothesized that regions that close during reprogramming 
would overlap with the active enhancer/euchromatin marks H3K27ac and H3K4me1 in 
fibroblasts. Conversely, regions that open during neuronal reprogramming may overlap with 
heterochromatic H3K9me3 and H3K27me3 signatures pre-existing in fibroblasts.  
 We selected 70,661 regions commonly marked by H3K27ac and H3K4me1 and 5,843 
regions commonly marked by H3K9me3 and H3K27me3 in human fibroblasts based on the 
Roadmap Epigenome database (Roadmap Epigenomics et al., 2015). We confirmed regions 
with altered chromatin accessibility overlapped with these histone marks. Strikingly, we found 
that 1,128 ATAC signal peaks present in day 20 miNs that display increased accessibility during 
conversion overlapped with regions of fibroblasts marked by H3K9me3/H3K27me3, which were 
heterochromatic regions in fibroblasts. Whereas H3K27ac/H3K4me1 marked euchromatic 
regions in fibroblasts overlapped with 16,207 peaks that were closed in miNs (Figure 5H). GO 
enrichment analysis of genes associated with open chromatin regions in miNs that were marked 
by H3K9me3 or H3K27me3 in fibroblasts resulted in neuronal differentiation and function-
related terms (Figure S3B) In contrast, regions that lose chromatin accessibility in miNs were 
enriched with non-neuronal terms (Figure S3D). These results demonstrate the surprisingly 
potency of miR-9/9*-124 to open heterochromatin regions needed for neuronal development 
and to close enhancer regions that preexist in fibroblasts and are not active in neurons. Our 
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results collectively provide an unprecedented demonstration that microRNAs can change 
chromatin architecture to promote neuronal and repress fibroblast fates during the direct 
conversion of human fibroblasts to neurons.  
Chromatin Remodeling is Required for Direct Conversion 
 To determine if chromatin changes were necessary for cell fate conversion we knocked 
down the expression BRG1, a core component of BAF chromatin remodeling complex whose 
reduced function has been shown to collapse the overall chromatin architecture (Kadoch et al., 
2017). After 20 days of neuronal conversion, loss of BRG1 markedly decreased the amount of 
MAP2 positive cells when compared to a control shRNA (Figure S4A). ATAC-seq revealed 
regions which failed to open in response to miR-9/9*-124 in the absence of BRG1 (Figure S4A). 
These regions were associated with neuronal GO terms in contrast to the fibroblast-related GO 
terms associated with regions that failed to close (Figure S4D). These data demonstrate the 
requirement of chromatin remodeling in cell fate conversion. Collectively, our transcriptome and 
ATAC-seq results provide mechanistic insight into the possibility of deriving additional clinically 
relevant neuronal subtypes through miRNA-mediated conversion in addition to cortical and 
striatal medium spiny neurons (Victor et al., 2014; Yoo et al., 2011). 
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Figure S1, Related to Figure 1  
 
MiRNA-Mediated Conversion into Neuronal Fate is Stable  
(A) Detailed schematic of miR-9/9*-124 direct conversion protocol. 
(B) Combined plot of the current (I) - voltage (V) relationship for every neuron recorded.  
(C) Tabulated values of miN resting membrane potentials. 
(D) Gap-free recording of miN resting membrane potential. 
(E) Tabulated values of miN capacitance values 
(F) MiR-9/9*-124 was ectopically expressed under a doxycycline (DOX) inducible promoter in 
22 year old human fibroblasts for 30 days then DOX was removed from the media and cells were 
cultured for an additional 30 days. Stable adoption of the neuronal fate was assayed by 
immunostaining for the pan-neuronal markers MAP2, NeuN, TUBB3 and NCAM. To assay if 
cells remained post-mitotic cells were stained with the proliferative marker ki-67. Scale bar = 
20µm. 
All data are represented as mean ± SEM. 
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Figure S2, Related to Figure 2 
 
Widespread Expression Changes in Epigenetic Modifiers During Reprogramming 
Heatmaps show expression changes observed between miNs and fibroblasts within a subset of 
proteins that recognize or modify distinct parts of the epigenome 
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Figure S3, Related to Figure 5 
 
Pre-existing Heterochromatic Neuronal Loci Open in Response to miR-9/9*-124 
Expression. 
(A) Top GO terms associated term with promoter regions that close during reprogramming from 
fibroblasts to miNs. 
(B) Closed regions in fibroblasts marked by H3K9me3 that open during neuronal reprogramming 
are enriched for neuronal GO terms. 
(C) Closed regions in fibroblasts marked by H3K27me3 that open during reprogramming are 
also enriched for neuronal GO terms. 
(D) Pre-existing distal H3K27ac and H3K4me1 marks within fibroblasts that close during 
neuronal reprogramming show GO terms related to general biological processes. 
(E) Genome browser snapshots demonstrating closing and loss of fibroblast gene expression 
(ECM1, MFAP5, and VIM). 
(F) Genome browser snapshots demonstrating neither opening or activation of gain of progenitor 
genes (SOX2, OLIG2 and ASCL1). 
(G) Genome browser snapshots demonstrating neuronal subtype gene loci that open, but do not 
show gene expression changes (GAD2 and GABRA2, GABAergic markers; TH, dopaminergic 
neuron marker). 
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Figure S4, Related to Figure 5  
 
Loss of BRG1 Prevents Neuronal Fate Acquisition 
(A) Adult human fibroblasts ectopically expressing miR-9/9*-124 and shBRG1 or shEGFP 
control for 20 days immunostained for the pan-neuronal marker MAP2 and fibroblast marker 
FSP1. Scale bars = 20µm. 
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(B) Quantification of (A) MAP2 and FSP1 positive cells over total number of cells (DAPI). For 
MAP2, only cells with processes at least three times the length of the soma were counted. Data 
are represented as mean ± SEM. shBRG1 n = 155 cells, shEGFP, n = 173 cells, 
(C) Heatmaps showing signal intensity in open and close chromatin peaks in shBRG1 and 
shEGFP. All open and closed chromatin regions were ranked according to maximum intensity 
across all samples.  
(D) The genomic distribution of open and closed chromatin regions.  
(E) GO terms showing biological function of closed (lost in shBRG1, red) and open (retained in 
shBRG1, blue) regions. 
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Materials and Methods 
Cell Culture 
Adult and neonatal human fibroblasts were obtained from commercial sources and 
maintained in fibroblast media comprised of Dulbecco’s Modified Eagle Medium (Invitrogen) 
supplemented with 15% fetal bovine serum (Life Technologies), 0.01% β- mercaptoethanol (Life 
Technologies), 1% non-essential amino acids, 1% sodium pyruvate, 1% GlutaMAX, 1% 1M 
HEPES buffer solution, and 1% penicillin/streptomycin solution (all from Invitrogen). Cells 
were never passaged more than 15 times. 
Plasmid construction and virus production. 
 Complementary cDNA was generated from adult human spinal cord (Clontech) from 
which individual motor neuron transcription factors (Figure S5A) were subcloned into the N174 
and N106 lentiviral vectors using standard techniques. Lentivirus was produced in 293le cells 
plated in 10cm dishes (6.5 x 10^6 cells per dish) via polyethylineimine (48 µL of 2 mg/mL, 
Polysciences) assisted transfection of 3rd generation packaging vectors (1.5 µg pMD2.G and 4.5 
µg psPAX2), and 6 µg of lentiviral backbone plasmid (e.g. pT-BCL-9/9*-124) 16 hours after 
initial plating. Media was changed the next day. After 2 days, media was harvested, filtered 
through a 0.45 µm polyethersulfone (PES) syringe filter and then concentrated by centrifugation 
at 70,000xG for 2 hours at 4°C. Virus collected from a single 10 cm dish was resuspended in 1 
mL of sterile PBS then aliquoted and stored at -80°C. Before each transduction, virus aliquots 
were spun at 5,000xG for 5 minutes at 4°C to remove debris. Control vector expressing non-
specific (NS) miRNA and BCL-XL was generated previously (Victor et al., 2014).  
Direct Conversion 
 To initiate direct conversion, 1.8x10^6 cells were seeded onto Costar 6 well cell culture 
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vessels (Corning; 300,000 cells/well). The following day, each plate was transduced with the 
following reprogramming cocktail: 750 uL of concentrated lentivirus containing the reverse 
tetracycline-controlled transactivator (rtTA; Addgene, 66810) and 500 µL of virus containing 
pT-BCL-9/9*-124 or pT-BCL-9/9*-124 plus 500 µl of each individual TF driven by the EF1α 
promoter in the presence of polybrene (8 µg/mL ; Sigma-Aldrich) all diluted up to 18 mL (3 mL 
per well) then spinfected at 37°C for 30 minutes at 1,000xG using a swinging bucket rotor. The 
following day media was changed to fresh fibroblast media (2 mL per well) supplemented with 
doxycycline (Dox; Sigma Aldrich, 1 µg/mL). After 2 days, fresh fibroblast media was changed 
and supplemented with Dox and antibiotics for respective vectors (Puromycin, 3 µg/ml; 
Blasticidin 5 µg/ml; Geneticin, 400 ug/mL; all from Invitrogen). Five days post-transduction 
cells were replated on to poly-ornithine/laminin/fibrobnectin (PLF) coated glass coverslips. 
Before PLF coating, glass coverslips were acid treated according to (Richner et al., 2015). To 
transfer cells, for each well of a 6 well plate, cells were first washed 2x with 1 mL sterile PBS. 
Then 320 µL of 0.25% Trypsin (Gibco) was added to each well then placed in an incubator. Cells 
were monitored every 2 minutes, as soon as cells began to detach (no more than 6 minutes) 1 ml 
of MEF media supplemented with 1 µg/mL Dox was added to each well. One by one, each well 
was gently triturated three times to remove remaining attached cells then transferred to a sterile 
1.5 mL Eppendorf tube. Cells were then spun at 200xG for 5 minutes at 37°C. The supernatant 
was aspirated and cells were gently resuspended in 300 µL MEF media supplemented with Dox. 
Cells were then drop-plated onto either 18 mm (150 µL per/c.s.; placed in 12 well plate) or 
12mm (60 µL per c.s.; placed in 24 well plate) coverslips. Cells were left to settle for 15 minutes 
in an incubator then each well was flooded with MEF media supplemented with 1 µg/mL Dox. 
The following day media was then changed to Neuronal Media (Sciencell) supplemented with 
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Dox, valproic acid (1 mM; EMD Millipore) dibutyryl cAMP (200 µM; Sigma-Aldrich), BDNF, 
NT-3, CNTF, GDNF (all 10 ng/ml, Peprotech), and Retinoic Acid (1 uM; Sigma-Aldrich) and 
antibiotics for each vector. Dox was replenished every two days and half the media was changed 
every 4 days. Drug selection was halted 14 days into conversion. A diagram of the 
reprogramming protocol is available in Figure S1.  
For time-course studies, the above reprogramming protocol was utilized with the 
following exception. In 3 day intervals starting on reprogramming day 9, a full media change 
excluding DOX was used to effectively remove DOX from the well at each timepoint. 
For DNA methylation profiling, 1.8x10^6 human neonatal fibroblasts were seeded onto 
10 cm plates (Corning). To achieve the cell number required for meDIP and MRE-seq human 
neonatal fibroblasts were utilized as adult fibroblasts were unable to expand to sufficient 
quantities. The following day, each plate was transduced with 10 ml of un-concentrated 
lentivirus containing media with a doxycycline inducible miR-9/9*-124 vector (Victor et al., 
2014) and polybrene (8 µg/mL ; Sigma-Aldrich). The following day media was changed 
to fresh fibroblast media (2 mL per well) supplemented with Dox. After 2 days, fresh fibroblast 
media was changed and supplemented with Dox and antibiotics for respective vectors (see Table 
1). Seven days post-transduction, cells were first washed 2x with 3 mL sterile PBS. Then 1 ml of 
0.25% Trypsin (Gibco) was added to each plate then placed in a 37oC tissue culture incubator. 
Cells were monitored every 2 minutes and as soon as cells began to detach (no more than 6 
minutes), 4 ml of MEF media supplemented with 1 µg/mL Dox was added to each plate. Cells 
were transferred to Primaria modified 10 cm plates (Corning) and 5 ml fresh fibroblast media 
supplemented with 1 µg/mL Dox was added to a final volume of 10 ml. The following day media 
was changed to Neuronal Media (Sciencell) supplemented with Dox, valproic acid (1 mM; EMD 
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Millipore) dibutyryl cAMP (200 µM; Sigma-Aldrich), BDNF, and NT-3 (all 10 ng/ml, 
Peprotech), Retinoic Acid (1 uM; Sigma-Aldrich), and 4% FBS. Dox was replenished every two 
days and half the media was changed every 4 days. 
Immunocytochemistry and cell counting 
 Cells were fixed using 4% formaldehyde for 18 minutes at room temperature (RT) then 
blocked and permeabilized for one hour at room temperature in PBS containing 0.3% Triton-
X100, 5% bovine serum albumin (Sigma-Aldrich), and 2% of either goat or donkey serum 
(Sigma-Aldrich). Primary antibodies were incubated overnight at 4°C in blocking buffer. Cells 
were then washed 3x and incubated with secondary antibodies conjugated to either Alexa-488, -
594 or -647, for one hour at room temperature. a-Bungarotoxin was incubated with secondary 
antibodies at a concentration of 1:200. Images were obtained on a Leica SP-2 Confocal 
Microscope. Quantifications were performed on at least 6 random fields of view in duplicate 
experiments. 
Electrophysiology 
 Whole-cell patch-clamp recordings were performed 35-40 days post-transduction. Data 
was acquired using pCLAMP 10 software with multiclamp 700B amplifier and Digidata 1550 
digitizer (Molecular Devices). Electrode pipettes were pulled from borosilicate glass (World 
Precision Instruments) and typically ranged between 5–8 MΩ resistance. Intrinsic neuronal 
properties were studied using the following solutions (in mM): Extracellular: 140 NaCl, 3 KCl, 
10 Glucose, 10 HEPES, 2 CaCl2and 1 MgCl2
 
(pH adjusted to 7.25 with NaOH). Intracellular: 
130 K- Gluconate, 4 NaCl, 2 MgCl2, 1 EGTA, 10 HEPES, 2 Na-ATP, 0.3 Na-GTP, 5 Creatine 
phosphate (pH adjusted to 7.5 with KOH). Membrane potentials were typically kept at -65 mV. 
In voltage-clamp mode, currents were recorded with voltage steps ranging from -20 mV to +90 
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mV. In current-clamp mode, action potentials were elicited by injection of step currents that 
modulated membrane potential from -10 mV to +35 mV. Data was collected in Clampex and 
initially analyzed in Clampfit (Molecular Devices). Further analysis was done in GraphPad 
Prism 7 (GraphPad Software). Liquid junction potential was calculated to be 15.0 mV and 
corrected in calculating resting membrane potential according to previously published methods 
(Barry, 1994).  
RNA-Seq library preparation and sequencing 
 Day 30 miNs and starting human adult fibroblasts (22 yr old) were extracted by RNeasy 
plus micro kit (Qiagen). The RNA samples with > 9.5 of RIN based on a 2100 Bioanalyzer were 
used for RNA-Seq library preparation. Library preparation and sequencing were performed by 
Genome Technology Access Center in Washington University School in St. Louis. Briefly 
mRNA was isolated by using SMARTer Ultra Low RNA Kit for Illumina sequencing 
(Clontech). All cDNA libraries, based on two biological replicates for each condition, were 
sequenced on Illumina Hi-Seq 2500 with single-end 50 bp read length.  
For RNA-seq time series data in Figure 3, total RNA was extracted from starting human 
adult fibroblasts (22 yr old) and day 3, 6, 10, and 20 miNs by RNeasy plus micro kit (Qiagen). 
The RNA samples with > 9.5 of RIN based on a 2100 Bioanalyzer were used for RNA-Seq 
library preparation. Total RNA was processed for library construction by Cofactor Genomics 
(http://cofactorgenomics.com, St. Louis, MO) according to the following procedure: Briefly, 
total RNA was reverse-transcribed using an Oligo(dT) primer, and limited cDNA amplification 
was performed using the SMARTer® Ultra® Low Input RNA Kit for Sequencing – v4 (Takara 
Bio USA, Inc., Mountain View, CA ). The resulting full-length cDNA was fragmented and 
tagged, followed by limited PCR enrichment to generate the final cDNA sequencing library 
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(Nextera® XT DNA Library Prep, Illumina, San Diego, CA). Libraries were sequenced as 
single-end 75 base pair reads on an Illumina NextSeq500 following the manufacturer's 
instructions by Cofactor Genomics. 
RNA-Seq data analysis  
More than 35 million reads of each RNA-seq data were aligned to human genome 
assembly GRCh 37. For differential expression analysis, edgeR and limma were used. Genes 
with low read counts, regarded as genes not expressed at a biologically meaningful level were 
filtered out before read normalization. The cut-off for low read count was counts per million 
(CPM) <1 in at least any two samples across the experiment. Reads for each sample were 
normalized by the edgeR method of trimmed mean of M-values (TMM). The quantitative 
difference of read counts between miNs and starting fibroblast samples were evaluated by 
carrying out limma and graphically represented by Glimma. Gene enrichment analysis for 
differentially expressed genes was performed using Metascape Gene Annotation and Analysis 
Resource tool. 
For RNA-seq time series data in Figure 3, quality control, alignment, clustering, 
normalization, and expression comparison were performed by Cofactor Genomics 
(http://cofactorgenomics.com, Saint Louis, Missouri, USA). Raw sequence data in FASTQ 
format were assessed for quality (FastQC, 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and ribosomal RNA content 
(sortmeRNA, http://bioinfo.lifl.fr/RNA/sortmerna/). NovoAlign (Novocraft, 
http://novocraft.com) was used to align reads to a set of transcript sequences. NovoAlign 
parameters were set to allow multiple alignments to the transcriptome set to allow for isoforms. 
Alignments to the genome were performed using STAR (https://github.com/alexdobin/STAR). 
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Only unique alignments to the genome were allowed. The genome alignment loci from all 
samples were combined and clustered to generate genomic loci (“patches”) with contiguous read 
coverage. Patches overlapping reference genome annotation loci were labelled as such. For each 
transcript or patch, the RPKM expression value was calculated for each sample. These RPKM 
values are the basis for expression comparison and statistics generation. For each replicate group, 
the mean and coefficient of variation for each transcript or patch were calculated across the 
expression values for the samples in that group. These means were considered to be the 
expression values for the replicate group. P-values were calculated between the means of each 
pair of replicate groups using a Welch’s t-test corrected for FDR by the method of Benjamini-
Hochberg 
DREM Analysis 
The Dynamic Regulatory Events Miner (DREM) and cDREM were used to integrate time 
series gene expression data with predicted TF-gene binding interactions (top 100 genes per 
PWM from Ernst et al., 2010 to identify patterns of temporal gene expression patterns and the 
associated regulators. The log fold change of 7310 DE genes (fold-change > 10; q-value < 0.1) 
was used to generate all paths in Figure 3. 
Methylated DNA immunoprecipitation sequencing 
MeDIP-seq was performed as in Maunakea et al. (Maunakea et al., 2010). Five 
micrograms of genomic DNA was sonicated to a fragment size of ~100-400 bp using the 
Bioruptor sonicator (Diagenode). End-repair, addition of 3’-A bases and PE adapter ligation with 
2 µg of sonicated DNA was performed according to the Illumina Genomic DNA Sample Prep 
Kit protocol. Adapter-ligated DNA fragments were size selected to 166-366 bp and purified by 
gel electrophoresis. DNA was heat denatured and then immunoprecipitated with 5-
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methylcytidine antibody (Eurogentec; 1 µg of antibody per 1 µg of DNA) in 500 µl of 
immunoprecipitation buffer (10 µM sodium phosphate, pH 7.0, 140 mM sodium chloride and 
0.05% Triton X-100) overnight at 4 °C. Antibody/DNA complexes were isolated by addition of 
1 µl of rabbit anti-mouse IgG secondary antibody (2.4 mg ml-1, Jackson Immunoresearch) and 
100 µl protein A/G agarose beads (Pierce Biotechnology) for 2 h at 4 °C. Beads were washed 
nine times with immunoprecipitation buffer and then DNA was eluted in TE buffer with 0.25% 
SDS and 0.25 mg ml-1 of proteinase K for 2 h at 50 °C. DNA was then purified with the Qiagen 
QIAquick kit and eluted in 30 µl EB buffer. Ten microliters of DNA was used for a PCR-
enrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size selected (220-
420 bp) and purified by gel electrophoresis. Methylated DNA enrichment was confirmed by PCR 
on known methylated (SNRPN and MAGEA1 promoters) and unmethylated (a CpG-less 
sequence on chromosome 15 and glyceraldehyde 3-phosphate dehydrogenase promoter) 
sequences. DNA libraries were checked for quality by Nanodrop (Thermo Scientific) and 
Agilent DNA Bioanalyzer (Agilent). Reads were aligned to hg19 using BWA and pre-processed 
using methylQA (an unpublished C program; available at http://methylqa.sourceforge.net/). 
Detailed library construction protocols for MRE-seq and MeDIP-seq are publically available at 
the NIH Roadmap Epigenomics project website 
(http://www.roadmapepigenomics.org/protocols/type/experimental/.  
Methylation-sensitive restriction enzyme sequencing 
MRE-seq was performed as in Maunakea et al. (Maunakea et al., 2010), with 
modifications as detailed below. Five parallel restriction enzyme digestions (HpaII, Bsh1236I, 
SsiI(AciI) and Hin6I (Fermentas), and HpyCH4IV (NEB)) were performed, each using 1 µg of 
DNA per digest for each of the samples. Five units of enzyme were initially incubated with DNA 
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for 3 h and then an additional five units of enzyme were added to the digestion for a total of 6 h 
of digestion time. DNA was purified by phenol/chloroform/isoamyl alcohol extraction, followed 
by chloroform extraction using phase lock gels. Digested DNA from the different reactions was 
combined and precipitated with one-tenth volume of 3 M sodium acetate (pH 5.2) and 2.5 
volumes of ethanol. The purified DNA was size selected and purified (50-300 bp) by gel 
electrophoresis and Qiagen MinElute extraction. Library construction was performed as per the 
Illumina Genomic DNA Sample Prep Kit protocol with the following modifications. During the 
end-repair reaction, T4 DNA polymerase and T4 PNK were excluded and 1 µl of 1:5 diluted 
Klenow DNA polymerase was used. For the adapter ligation reaction, 1 µl of 1:10 diluted PE 
adapter oligo mix was used. Ten microliters from the 30 µl of purified adapter ligated DNA was 
used for the PCR enrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size 
selected and purified (170-420 bp) by gel electrophoresis and Qiagen QIAquick extraction. DNA 
libraries were checked for quality by Nanodrop (Thermo Scientific) and Agilent DNA 
Bioanalyzer (Agilent). Reads were aligned to hg19 using BWA and pre-processed using 
methylQA. MRE reads were normalized to account for differing enzyme efficiencies and 
methylation values were determined by counting reads with CpGs at fragment ends (Maunakea 
et al., 2010). 
Differential DNA-methylated region analysis 
The M&M statistical model (Zhang et al., 2013), which integrates MeDIP-seq and MRE-
seq data to identify differentially methylated regions between two samples was implemented 
with a window size of 500 bp and a q-value (false discovery rate (FDR)-corrected P-value) 
cutoff of 5e-2. This cutoff was determined from Figure 3C, where only 1 DMR was detected at 
day 10 (miN day 10 vs. Ctrl day 10). For Figure 3B, only regions that were considered DMRs (q-
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value < 1e-5) at both day 20 (miN day 20 vs. Ctrl day 20) and day 30 (miN day 30 vs. Ctrl day 
30) are displayed. 
GO enrichment analyses 
DNA methylation GO analyses of MGI (Mouse Genome Informatics) expression (Smith 
et al., 2014) presented in Figure 3D were performed using the GREAT package (McLean et al., 
2010). Gene regulatory domains were defined by default as the regions spanning 5 kb upstream 
and 1 kb downstream of the TSS (regardless of other nearby genes). Gene regulatory domains 
were extended in both directions to the nearest gene’s basal domain, but no more than a 
maximum extension in one direction. The top 100 most significant overlapping DMRs from day 
20 (miN day 20 vs. Ctrl day 20) and day 30 (miN day 30 vs. Ctrl day 30) were used as input. For 
Figure 3G, GO analyses were performed using Metascape (Tripathi et al., 2015) with a minimum 
enrichment of 1.5, a minimum overlap of 3, and a p-value cutoff of 0.01 using all demethylated 
or methylated DMRs at day 30 (miN day 30 vs. Ctrl day 30) that were either up- or down-
regulated, respectively, by RNA-seq at day 35 using a cutoff of 2.5 logFC.  
Genomic features 
DMRs from day 30 (miN day 30 vs. Ctrl day 30) were segregated into exons, introns, 
intergenic regions, 3’ UTRs, 5’ UTRs, non-coding regions, promoter-TSSs, and TTSs by using 
the annotatePeaks program provided by HOMER (Heinz et al., 2010). 
ATAC-sequencing library preparation and data processing 
ATAC-seq was performed as previously described (Buenrostro et al., 2013). Briefly, 
50,000 cells were collected for ATAC-seq library preparation at Ctrl day 10, miNs day 10, miNs 
day 20, shBRG1 Day20 and shEGFP day 20. Transposition reaction was carried out with 
Nextera Tn5 Transposase for 30 min at 37 °C. Library fragments were amplified for optimal 
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amplification condition. Final libraries were purified using AMPure XP beads (Ampure) and 
sequenced with 50 bp paired-end reads on Illumina HiSeq 2500.  
More than 50 millions of ATAC-seq reads were trimmed for Nextera adapter sequences 
using TrimGalore and aligned to hg19 human genome assembly using bowtie2 with parameters -
-very-sensitive --maxins 2000 --no-discordant –-no-mixed. Duplicate reads were discarded with 
Picard and uniquely mapped reads were used for downstream analysis. Peaks were called using 
Homer with parameters findPeaks -region -size 150 -minDist 300. Peaks called from all the 
samples were combined together and raw reads mapped on the combined peaks were counted 
using HTSeq count. Differential peaks between any two different samples were identified using 
edgeR with a cut-off: a fold-change threshold of 1.5 and FDR < 0.01. Differential peaks were 
regarded as peaks that are gained or lost at each time point. 
Gained peaks at miNs D10 and D20 were combined together and defined as open 
chromatin regions. Conversely, all lost peaks at miNs D10 and D20 were defined as close 
chromatin regions. The genomic features in the differential open and close chromatin regions 
were distributed by the CEAS software (Shin et al., 2009). We annotated Ref-seq genes that are 
most nearest located from differential peaks with Homer annotatePeaks command. Based on 
those genomic distribution and peak annotation, we defined the promotor regions (-/+ 2Kb of 
TSS) and distal regions (all peak positions except the promoter regions). GO enrichment analysis 
were performed by Metascape or the Gene Ontology. All heatmaps were made based on 
normalized signal intensity values (i.e. log2CPM) of each sample on relevant specific regions. 
All histone mark ChIP-seq data were obtained from Roadmap Epigenome database of human 
fibroblasts (Roadmap Epigenomics et al., 2015). To identify histone mark-occupied chromatin 
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accessibility during reprogramming, we compared each histone ChIP-seq data with open and 
close chromatin regions based on ATAC-seq. We confirmed that most open and close chromatin 
peaks overlapped with histone mark-ChIP peaks were found in regions outside of promoter 
regions (+/- 2Kb of TSS). Open and close chromatin regions excluding the promoter regions 
were then used to compare with histone ChIP-seq data and perform further GO enrichment 
analysis. 
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Abstract 
 Motor neurons provide the electrical bridge between the brain and musculature enabling 
vertebrates to interact with their environment. The inherent complexity in motor behaviors 
requires a robust developmental program to ensure proper specification, differentiation, and 
connection of motor neurons. A large amount of progress has been made in the study of each of 
these aspects of motor neuron biology. This work has been inspired by the disorders that arise 
when this intricate system is perturbed by disease or injury. Most well known of the motor 
neuron disorders are Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA) and 
Spinal Cord Injuries (SCI). Despite our increased understanding of motor neuron biology, a cure 
for any of these debilitating diseases has not been found. One of the greatest hurdles in studying 
neurodegenerative diseases is access the affected cell types. The location and absolute necessity 
of neurons within the human body prohibits their extraction for further studies. Furthermore, 
post-mortem samples cannot be expanded in culture since neurons are post-mitotic, thus 
preventing the accumulation of cell numbers needed for proper experimentation. In the same 
vein, neurons lost in these diseases cannot be replaced by the host as there is little adult 
neurogenesis (Ming and Song, 2011). If it were possible to generate the neurons affected by 
these diseases in vitro, a valuable resource would open up both for neurodegenerative disease 
modeling and prospective regenerative therapies. Our lab has previously shown that the ectopic 
expression of the brain enriched miRNAs, miR-9/9* and miR-124 (miR-9/9*-124) is sufficient 
to convert human fibroblasts into a heterogeneous population of both excitatory and inhibitory 
neurons (Yoo et al., 2011). Importantly, this method robustly converts cells originating from 
adult humans, a cell type historically difficult to reprogram efficiently (Caiazzo et al., 2011; Ring 
et al., 2012; Vierbuchen et al., 2010). 
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 With the observation that neurodegenerative diseases often affect specific cell types we 
have sought to guide this conversion into distinct neuronal subtypes. We have found that ectopic 
co-expression of transcription factors enriched in specific regions of the brain and miR-9/9*-124, 
reprograms fibroblasts into the neuronal subtype that resides within the region of interest (Victor 
et al., 2014). For example, the introduction of transcription factors enriched in the striatum to the 
miRNA-mediated reprogramming process guides conversion into striatal medium spiny neurons 
(MSNs), the principle cell-type affected in Huntington’s disease. The ability of miR-9/9*-124 to 
open loci important in the acquisition and maintenance of multiple neuronal subtypes, including 
but not limited motor neuron loci, suggests that motor neurons could be derived through the 
addition of motor neurons transcription factors to miR-9/9*-124. In pursuit of this hypothesis I 
screened a pool of developmentally informed motor neurons transcription factors in the 
background of ectopic miR-9/9*-124 expression and assayed for the acquisition of motor neuron 
identity. I identified two transcription factors, ISL1 and LHX3, that when co-expressed with 
miR-9/9*-124 were sufficient to directly convert adult human fibroblasts into functional motor 
neurons. Further, these motor neurons share significant genetic networks with their in vivo 
mouse counterparts, suggesting that this reprogramming modality is capable of generating bona 
fide motor neurons.  
Main Text 
Instructing the miRNA-induced Neurogenic State to a Motor Neuron Fate 
 The deposition and removal of nucleosomes along regulatory elements within DNA 
inhibits or enables the binding of TFs, simultaneously facilitating and reinforcing cell-type 
specific gene expression programs (Jiang and Pugh, 2009). In our previous analyses we noted 
chromatin regions in miNs with enhanced accessibility were proximal to MNX1 and choline 
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acetyl transferase CHAT, two of the hallmark genes expressed by motor neurons (Fonnum, 
1973; Tanabe et al., 1998) (Figure 5I). Neither MNX1 nor CHAT mRNA levels were elevated in 
day 30 miNs after miR-9/9*-124 directed neuronal conversion, but we hypothesized the open 
chromatin would facilitate expression of these genes in response to motor neuron-specific TFs. 
To test this hypothesis we expressed a panel of TFs known to promote motor neuron identity 
(Figure S5A) in combination with ectopic miR-9/9*-124 expression, and assayed for MAP2 and 
MNX1 expression by immunostaining (data not shown). While all combinations resulted in 
MAP2 positive cells, only ISL1 and LHX3 robustly led to the generation of MNX1-positive cells. 
Co-expressing LHX3 and ISL1 with miR-9/9*-124 in adult human fibroblasts from 22-, 42-, 56- 
and 68-year old donors resulted in MAP2, TUBB3 and NCAM-positive cells with complex 
neuronal morphologies (Figures 6A and 6B). Approximately 80% of cells positive for DAPI 
staining were positive for TUBB3, MAP2 and NCAM expression (Figure 6C). The majority of 
converted cells displayed nuclear staining of MNX1 (~85% of TUBB3 positive cells in each line, 
Figures 6D and 6E). Similarly, cytoplasmic CHAT protein and SMI-32 (a neurofilament protein 
found in motor neurons) were detected in ~80% of TUBB3 positive cells within each age group 
(Figure 6D and 6E).  
  Interestingly, ISL1 and LHX3 alone were not sufficient to induce neuronal conversion 
when co-expressed with a non-specific miRNA (miR-NS) (Figure S5B), supporting the notion 
that miR-9/9*-124 is necessary for the subtype-specifying activities of ISL1 and LHX3. Motor 
neuron conversion induced by miR-9/9*-124 plus ISL1 and LHX3 was stable, displaying 
neuronal morphologies, cell cycle exit, and motor neuron marker expression for 30 days after 
doxycycline removal (Figure 6F).  
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Figure 6. MiRNA-Induced Neuronal Competence Enables Motor Neuron Transcription 
Factors, ISL1 and LHX3, to Determine Motor Neuron Identity. 
(A) Schematic of neuronal induction paradigm using miR-9/9*-124 plus ISL1 and LHX3. 
(B) Representative immunohistochemistry for pan-neuronal markers in neurons generated from 
fibroblasts through 35 days of ectopic miR-9/9*-124, ISL1, and LHX3 co-expression. Fibroblasts 
were isolated from a 22 year old female donor. Scale bars = 20µm. 
(C) Quantification of 4 independent primary human fibroblast lines from both male and female 
donors stained with TUBB3, MAP2 and NCAM. Percentages represent total number of positive 
cells over all cells (DAPI) and are represented as mean ± SEM. Cells analyzed: 22 yr old 
N=TUBB3 325, MAP2 219, NCAM 275; 42 yr old N=TUBB3 304, MAP2 236, NCAM 129; 56 yr 
old N=TUBB3 275, MAP2 279, NCAM 213; 68 yr old N=TUBB3 282, MAP2 234, NCAM 190.  
(D) Expression and correct localization of motor neuron markers in neurons converted by miR-
9/9*-124 and ISL1/LHX3 as demonstrated by immunohistochemistry. MNX1, (top), CHAT 
(middle) and SMI-32 (bottom). Scale bars = 20µm. 
(E) Quantification of (D) represents the total percentage of MNX1, CHAT and SMI-32-positive 
cells over TUBB3-positive cells. Data are represented as mean ± SEM. Cells analyzed: 22 yr 
old N=MNX1 256, CHAT 256, SMI-32 113; 42 yr old N= MNX1 151, CHAT 151, SMI-32 283; 56 
yr old N= MNX1 207, CHAT 207, SMI-32 174; 68 yr old N= MNX1 151, CHAT 151, SMI-32 96. 
(F) After 30 days of neuronal conversion by ectopic miR-9/9*-124 expression, doxycycline was 
removed and cells were cultured for an additional 30 days. Immunocytochemistry showing 
motor neurons produced by miR-9/9*-124 plus ISL1 and LHX3 (Moto-miNs) remain Ki-67 
negative (2nd panel), retain expression and localization of the neuronal proteins TUBB3, NEUN, 
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and MAP2 (2nd and 3rd panel), and express the motor neuron proteins MNX1 and CHAT (4th and 
5th panel). Scale bars = 20µm. 
See also Figure S5. 
Electrophysiological properties of Moto-miNs 
 Motor neurons produced from fibroblasts by co-expression of miR-9/9*-124, ISL1 and 
LHX3 (Moto-miNs) demonstrated robust inward and outward currents in response to 
depolarizing steps (Figure 7A) and displayed action potential trains through the injection of step-
wise depolarizations (Figures 7B and S5C). The visualization of single traces recorded at 
individual current steps revealed the characteristic hyperpolarization following each action 
potential seen in mature neurons (Figure 7C). To assess the percentage of functionally mature 
Moto-miNs, we patched 45 randomly chosen Moto-miNs from 22-year-old and 68-year-old 
donors. All Moto-miNs fired APs. Most cells fired multiple APs (80% n=20 and 74% n=25) while 
single APs were observed in ~20-25% of the patched cells (Figure 7D). Gap-free recordings in 
current clamp mode revealed cells capable of firing spontaneous action potentials (Figure 7E), 
demonstrating the excitability of these cells. Similar I-V curve relationships were observed 
between donors and firing patterns (Figure 7F). Peak inward currents were substantially higher 
than those observed in miNs (Figure S6A). Lastly, resting membrane potentials in all Moto-miNs 
tested were hyperpolarized (Figure 7G; 22 yr old, -67.2 mV ± 3.3 mV; 68 yr old, -72.8 mV ± 2.0 
mV, S.E.M.). Coupled with the increased proportion of cells that fire multiple APs these data 
suggest that the addition of ISL1 and LHX3 to miR-9/9*-124 produced more mature neurons 
than exposure to miR-9/9*-124 alone.  
 The ability of motor neurons to control voluntary muscle movement stems from their 
ability to form neuromuscular junctions (NMJs), unique synapses formed between motor 
neurons and muscle cells. The formation of NMJs was visualized through the co-localization of 
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EGFP-labeled Moto-miNs, Alexa-fluor-594 Bungarotoxin (BTX, a toxin that binds to the nicotinic 
acetylcholine receptor (AChR) of NMJs), and myosin heavy chain. BTX puncta were not 
observed in the absence of Moto-miNs (Figure 7H, left inset). In contrast, Moto-miNs were able 
to induce characteristic BTX-clustering in close apposition with EGFP labeled neurons and 
myotubes (Figure 7H) indicating the formation of putative NMJs. 
Transcriptional Profiling of Moto-miNs 
 To fully characterize the acquisition of a motor neuron fate and assess the contribution 
of ISL1 and LHX3, we profiled the transcriptome of 22-yr-old starting fibroblasts, miNs and 
Moto-miNs by microarray. We again observed the loss of fibroblast gene expression (for 
example, S100A4, VIM and COL13A1), and the gain of a pan-neuronal identity (for example, 
MAP2, NEFL, SNAP25 and SCN1A) 35 days after the expression of miR-9/9*-124 (Figure 7I). 
Expression of motor neuron-specific genes was not significantly different between starting 
fibroblasts and miNs. While the addition of ISL1 and LHX3 to miR-9/9*-124 did not significantly 
change the expression of pan-neuronal genes when compared to miNs (Figure 7J), ISL1 and 
LHX3 selectively activated key motor neuron genes including MNX1, CHAT, VACHT, LMO1 and 
LMO4 (Figure 7J). We further validated the loss of fibroblast identity and gain of motor-neuron 
identity in Moto-miNs derived from 42-, 56- and 68-year-old donors by qRT-PCR using RNA 
from human spinal cord as a positive control (Figure 7K). In addition, we observed dramatic 
upregulation of miR-218, a recently identified motor neuron-specific microRNA (Amin et al., 
2015; Thiebes et al., 2015) in Moto-miNs (Figure 7L). 
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Figure 7. Functional Properties and Gene Expression Profile of Moto-miNs 
(A) Representative traces of inward sodium and outward potassium whole-cell currents. 
(B) Repetitive AP waveforms in response to 500 ms current injections recorded from Moto-miNs 
converted in monoculture. 
(C) Representative waveforms of a single Moto-miN at increasing current injections. 
(D) Summary of firing patterns observed in Moto-miNs converted from both old and young 
donors. 68 yr old 80% multiple (N=20), 22 yr old 74% multiple (N=25).  
(E) Spontaneous firing activity was observed in a small percentage of Moto-miNs (3/20). 
(F) Combined plot of the current (I) - voltage (V) relationship for every Moto-miN recorded. Data 
are represented as mean ± SEM. 
(G) Moto-miNs converted from both young and old donors are hyperpolarized, demonstrating 
mean resting membrane potentials of -67.2mV and -72.8mV, respectively. Data are represented 
as mean ± SEM. 
(H) Staining of Moto-miNs cultured with differentiated human myotubes. Moto-miNs were 
labeled with synapsin-EGFP via viral transduction and then plated onto human myotubes.  
Myotube only cultures did not have α-Bungarotoxin-594 (red) puncta (top left inset). Scale bar = 
20µm. 
(I) Scatterplot comparing the mean gene expression of starting fibroblasts from a 22 year old 
donor (y-axis) and miNs generated from the same individual (x-axis). Plot highlights a selection 
of pan-neuronal and fibroblast-specific genes in green text. Blue = log2FC < -2.5 and p < 0.05, 
(more abundant in fibroblasts) grey = log2FC >-2.5 and < 2.5 p>.05 (no significant difference), 
and red = log2FC > 2.5 and p < 0.05 (more abundant in miNs).  
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(J) Scatterplot comparing the mean gene expression of miNs from a 22-year old donor (y-axis) 
and Moto-miNs generated from the same individual (x-axis). Plot highlights a selection of pan-
neuronal and motor neuron-specific genes in green text. Blue = log2FC < -2.5 and p < 0.05, 
(more abundant in miNs) grey = log2FC >-2.5 and < 2.5 p>.05 (no significant difference), and 
red = log2FC > 2.5 and p < 0.05 (more abundant in Moto-miNs).  
(K) Moto-miNs generated from multiple donors have lower mRNA levels for fibroblast genes and 
higher mRNA levels for motor neuron-specific genes. Moto-miNs were analyzed by qRT-PCR 
35 days post-transduction. Human spinal cord RNA served as a positive control (normalized to 
42 yr fibroblasts, ΔΔct method). Data are represented as mean ± SEM 
(L) MiR-9/9*-124 and ISL1/LHX3 activate the expression of the motor neuron specific miRNA, 
miR-218. RNA was isolated from fibroblasts and Moto-miNs 35 days post-transduction and 
analyzed by qRT-PCR. Data are represented as mean ± SEM 
(M) Moto-miNs retain donor fibroblast HOX gene expression pattern as demonstrated by qRT-
PCR. Δct method. Data represent Δct values for each biological replicate (3 separate Moto-miN 
conversions). 
See also Figure S6 and S7. 
 Next, we used the cell type-specific enrichment analysis tool (CSEA) (Xu et al., 2014) to 
test whether the gene expression profile within each population of miNs and Moto-miNs would 
be associated with distinct subtypes of in vivo neurons. When queried with a gene list, CSEA 
identifies neuronal subtypes that show significant enrichment in genes from the input list through 
curated transcriptomic data. Our CSEA analysis of the 100 most enriched genes within Moto-
miNs identified two subtypes, brainstem motor neurons and spinal motor neurons, to be 
significantly associated. No subtype specificity was assigned to the miN transcriptome (Figure 
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S6B). This unbiased bioinformatics approach further supports the motor neuron identity of 
converted Moto-miNs.  
 Lastly, HOX gene expression patterns were compared by qRT-PCR between starting 
fibroblasts and Moto-miNs. Interestingly, we observed a high correlation (R2 = 0.88) between 
the expression levels of HOX genes before and after conversion within each of the defined 
spinal cord regions tested, indicating Moto-miNs retain the positional identity that existed in 
original fibroblasts (Figure 7M, S6C).  
Transcriptional Activation of ISL1 and LHX3 Genomic Targets 
 An alternative approach for generating motor neurons is forced expression of NGN2, 
ISL1, and LHX3 in human embryonic stem cells (ESCs) (Mazzoni et al., 2013). We compared 
the genomic targets of ISL1 and LHX3 identified by Mazzoni et al. through ChIP-seq to genes 
whose expression increases in Moto-miNs compared to miNs. Surprisingly, we identified a large 
cohort of overlapping genes (323) that include numerous hallmark motor neuron markers 
(Figure S7A), suggesting that ISL1/LHX3 activate expression of a core gene regulatory network 
that underlies the specification of diverse cellular states towards motor neurons. 
Comparison of Moto-miNs to Endogenous Spinal Cord Motor Neurons 
 The inability to obtain a pure population of motor neurons from humans prevents direct 
transcriptional comparisons between Moto-miNs and their human in vivo counterparts. 
Therefore, we directly compared Moto-miNs to fully differentiated in vivo mouse motor neurons. 
To interrogate the gene expression of motor neurons within the large heterogeneity of cell-types 
present in the spinal cord, we performed Translating Ribosomal Affinity Purification (TRAP) 
followed by RNA-seq (Figure S7B). The use of two mouse lines expressing EGFP tagged 
ribosomes (one line under the pan-neuronal SNAP25 promoter, and the other through the 
CHAT promoter), enabled the enrichment and subsequent sequencing of actively transcribed 
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mRNA in all neurons and motor neurons within the spinal cord. We also profiled the 
transcriptome of the entire spinal cord as an additional ‘pre-IP’ control. Comparisons between 
CHAT pre-IP controls and CHAT-TRAP transcripts confirmed significant enrichment of motor 
neuron markers (Figure S7C, left) by the TRAP procedure. To further separate motor neuron 
enriched genes from common neuronal genes we first normalized CHAT-TRAP and SNAP-25 
datasets to their pre-IP controls, then directly compared the normalized gene expression values. 
This analysis revealed the co-expression of pan-neuronal genes such as MAP2, NRCAM, 
SCN1A and TUBB3 and highly enriched for motor neurons transcripts such as SLC18A3 
(VACHT), CHAT and MNX1 (Figure S7C, right). This dataset also serves as a resource for 
genes enriched in spinal cord neurons over all SNAP25 expressing neurons within the spinal 
cord. To that end, we compared differentially expressed mouse spinal cord motor neuron genes 
to genes enriched in Moto-miNs over miNs. We observed a significantly larger overlap between 
Moto-miNs and mouse motor neurons than expected by chance (Fisher’s exact test p = 3.522e-
06), indicating that Moto-miNs and endogenous mouse motor neurons utilize similar genetic 
networks. This includes expression of canonical motor neuron markers such as, SLIT2 and 
SLIT3, host genes for the motor neuron specific miRNA, miR-218 (Amin et al., 2015) (Figure 
S7D). Altogether, our in depth analyses of Moto-miNs at cellular, functional and transcriptomic 
levels confirm that co-expression of miR-9/9*-124 and ISL1/LHX3 can directly convert adult 
fibroblasts into spinal cord motor neurons. 
DISCUSSION 
  MiRNA-mediated neuronal conversion appears to be distinct from current models of cell 
fate reprogramming. Two models of lineage reprogramming have been proposed: one based on 
transcription factor cooperativity and positive feedback loops (Jaenisch and Young, 2008; Soufi 
et al., 2012; Vierbuchen and Wernig, 2012), and the other proposes that the “on-target” pioneer 
activity of a TF initiates and enables additional TFs to assist in cellular conversion (Wapinski et 
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al., 2013). In stark contrast, canonical gene regulation by miRNAs requires the removal of 
information through translational repression and transcript degradation. This mode of repression 
in conjunction with the multitude of anti-neurogenic genes targeted by miR-9/9*-124 suggests 
miRNA-mediated reprogramming acts through an alternative mechanism. We propose miR-
9/9*-124 expression in non-neuronal somatic cells initiates gradual, yet active changes in the 
activities of multiple chromatin modifiers while simultaneously repressing anti-neuronal genes 
and activating neuronal genes culminating in a binary cell-fate switch. This model is supported 
by the rapid cell cycle exit observed upon ectopic miR-9/9*-124 expression, the subsequent 
neuronal switching within chromatin modifiers, steady increase in epigenetic and transcriptional 
changes, and the time scale in which conversion takes place. 
Chromatin Remodeling Accompanies Cell Fate Conversion 
  In this study, we reveal the surprising potency of miR-9/9*-124 for remodeling chromatin 
and altering DNA methylation. Surprisingly, preexisting neuronal loci within the heterochromatic 
regions in human fibroblasts opened up in response to miR-9/9*-124. These data suggest the 
robustness of miRNA-mediated reprogramming observed in human cells could stem from their 
ability to induce epigenetic changes. Cellular processes and identity are governed by the 
cumulative action of multiple levels of genome regulation and it is unlikely a single genetic 
component downstream of miR-9/9*-124 mediates these changes and ultimately cell fate 
conversion. For example, almost every level of epigenetic remodeling participates in the 
induction of pluripotency (Takahashi and Yamanaka, 2016). Instructions operating through 
multiple levels of genetic and epigenetic regulation are likely required for true cell-fate 
conversion. Our thorough characterization of miR-9/9*-124 induced transdifferentiation of 
human fibroblasts into functional neurons highlights molecular processes that are critical to cell 
fate conversion. 
 74 
A Modular Neuronal State 
The plastic neuronal platform presented here affords modularity to direct cell fate conversion. 
Numerous studies in developmental neuroscience have identified subtype-specific TFs or 
terminal selector genes that could be incorporated in neuronal reprogramming technology. Yet, 
identifying molecules capable of overcoming the cell-fate barrier present in human somatic cells 
and eliciting a permissive environment in which terminal selector genes can act has proven to 
be challenging. We demonstrate this property by generating a neuronal population highly 
enriched in spinal cord motor neurons from human adult fibroblasts through the coexpression of 
miR-9/9*-124, ISL1 and LHX3. Because motor neurons are the major neuronal subtype affected 
in Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA), the robustness and 
specificity of neuronal conversion employing miRNAs and motor neuron TFs may pave the way 
towards generating patient-specific MNs for disease modeling. 
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Figure S5, Related to Figure 6 
Identification of Transcription Factors For Defining Motor Neuron Specific Conversion 
(A) Candidate motor neuron transcription factors and factor combinations that co-expressed with 
miR-9/9*-124 in human fibroblasts. 
(B) Immunocytochemistry of adult human fibroblasts overexpressing a non-specific miRNA 
(miR-NS) and ISL1/LHX3 (left) or miR-9/9*-124 and ISL1/LHX3 (right) for 35 days. Images 
demonstrate the necessity of miR-9/9*-124 for opening the neurogenic potential of human 
fibroblasts. Scale bar = 20µm.  
(C) Additional representative inward/outward whole-cell currents and repetitive AP waveforms 
generated from whole cell patch clamp recordings of Moto-miNs. Images show the patch 
clamped cells. 
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Figure S6, Related to Figure 7 
Addition of ISL1/LHX3 Increases Functional Maturity and Generates Motor Neuron 
Transcriptional Network 
(A) Peak inward current measured during voltage clamp mode of miNs and Moto-miNs reveals 
increased peak inward current in Moto-miNs (-3,189 pA ± 214 pA) compared to miNs (-919 pA 
±113 pA). Data are represented as mean ± SEM. 
(B) Cell Type-specific Enrichment Analysis (CSEA) tool reveals the top 100 most significantly 
expressed genes in miNs do not enrich for defined neuronal subtypes (left), while the top 100 
most significantly expressed genes in Moto-miNs are enriched in cholinergic motor neurons in 
the brain stem and spinal cord. 
(C) HOX gene expression analysis by qRT-PCR in 42 year old female and 56 year old male 
donor fibroblasts before and after conversion confirms that Moto-miNs retain donor fibroblast 
HOX gene expression patterns. Data represent Δct values for each biological replicate (3 separate 
Moto-miN conversions). 
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Figure S7, Related to Figure 7 
Direct Comparison of Moto-miN Transcriptome to in vivo Mouse Motor Neurons by 
Translating Ribosomal Affinity Purification (TRAP) Sequencing. 
(A) Venn Diagram depicting the number of ISL1/LHX3 ChiP-seq peaks identified by Mazzoni et 
al. during ISL1/LHX3 directed ES to motor neuron differentiation (3,486) and genes enriched in 
Moto-miN transcriptome (775). Heatmap shows overlapping activated genes (323) include 
hallmark motor neuron markers. 
(B) Schematic of TRAP-Seq strategy used to identify transcripts in all neurons (SNAP-25 
genetic driver) and motor neurons (CHAT genetic driver) in mouse spinal cord. TRAP is a 
method to precipitate actively translated mRNA bound to ribosomes using an antibody to EGFP-
L10A. 
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Materials and Methods 
Cell Culture 
 Cell culture and differentiation was performed as described in Chapter 3. 
Myotube Differentiation 
 Human myotubes were generated by differentiating human myoblasts using defined 
culture conditions (Steinbeck et al., 2016). Briefly, human skeletal myoblasts were cultured 
according to manufacturers recommendations (HSMM; CC-2580, Lonza) then were plated on 
matrigel (.1mg/mL) coated 12mm glass coverslips at a density of 80,000 cells/well. The 
following day HSMM’s were differentiated by switching media to skeletal muscle differentiation 
media comprised of a 1:1 mixture of DMEM F12 (Gibco) and Complete Neuronal Media + 2% 
Horse Serum (Gibco). Every 2 days 75% of the media was replaced with fresh differentiation 
media. After 10-14 days of differentiation, Moto-miNs 14 days into conversion and labeled with 
synapsin-eGFP via lentiviral transduction were replated onto the established myotubes at a 1:1 
ratio (i.e. one 12mm Moto-miN coverslip was replated on top of a 12mm myotube coverslip). 
The following day media was changed to complete neuronal media and cells were cultures for 2 
weeks. Dox was replenished every two days and half the media was changed every 4 days. After 
two weeks cells were fixed with 4% paraformaldehyde and processed for immunocytochemistry 
and a-Bungarotoxin staining. 
Electrophysiology 
 Electrophysiology was performed as described in Chapter 3 of this thesis. 
MicroArray analyses 
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Total RNA was extracted from miNs and Moto-miNs derived from 22 yr old donor 
fibroblasts alongside corresponding starting fibroblast controls using TRIzol (Thermo Fisher 
Scientific, Waltham, MA) according to the manufacturer’s instruction followed by extraction 
using chloroform and then ethanol precipitation. RNA quality was determined by the ratio of 
absorbance at 260 nm and 280 nm to be approximately 2.0. Samples for RNA microarray were 
then standardly prepped and labeled with Illumina TotalPrep kits (Thermo Fisher Scientific, 
Waltham, MA) for Agilent Human 4x44Kv1. Standard hybridization and imagine scanning 
procedure were performed according to the manufacturer's protocol at Genome Technology 
Access Center at Washington University School of Medicine, St. Louis. The intensity of the 
probes was imported into Partek and quantile normalized. Differentially expressed genes were 
identified using Partek with a cut-off of adjusted p-value <0.05 and over 2.5 log2 fold expression 
change. 
Translating ribosome affinity purification (TRAP) 
Translating ribosome affinity purification (Heiman et al., 2014) was performed on spinal 
cord dissections pooled from 3-4 mice 21 days post birth that were positive for the eGFP-L10A 
fusion ribosomal marker protein under either the Chat promoter (Tg(Chat-
EGFP/Rpl10a)DW167Htz) or the Snap25 promoter (Tg(Snap25-EGFP/Rpl10a)JD362Jdd). 
TRAP samples underwent immunopurification for four hours at 4°C. Both TRAP and pre-
immunopurification control RNA samples were extracted through TRIzol purification, DNase 
treatment, and Qiagen RNeasy Mini columns (74104). Quality and quantity of RNA was 
assessed using a Bioanalyzer 2100 RNA Pico Chip. Sequencing libraries were amplified using 
Nugen Amplification Kit Ovation® RNA Seq System V2 (7102). Genome Technology Access 
Center at Washington University in St. Louis performed adapter ligation and sequencing of the 
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libraries on the Illumina Hiseq2500. Three replicates of this procedure were analyzed.  
Analysis of TRAP RNA-Seq data 
RNA-Seq reads were mapped to Ensembl release 76 using STAR (analysis performed 
by Genome Technology Access Center at Washington University in St. Louis).  For downstream 
analyses, only those genes with >1 CPM in at least 3 samples, with an Ensembl gene biotype of 
"protein_coding," were retained. For gene symbols mapping to multiple Ensembl gene IDs, only 
the ID with the highest number of mapped reads was retained, resulting in a total of 14,009 genes 
used for downstream analyses. Using edgeR, read counts were fit to a negative binomial 
generalized log-linear model, and a likelihood ratio test was done to determine differential 
expression. 
Comparative analysis of RNA-Seq and microarray data 
For comparative analysis, only probes with a detected call in at least 1 of 6 samples was 
retained, resulting in 23,775 probes mapping to a gene symbol. Expression level was then 
averaged over all probes for each gene, resulting in a total of 15,333 genes that were used for 
comparative analysis, 10,736 of which were also present in the gene set retained from the RNA-
seq dataset (described above) after CPM filtering.  Within the genes retained in both datasets, the 
top differentially expressed genes between motor neurons and controls - CHAT  IP vs. SNAP25 
IP (logFC > 1 and p < 0.05) in the RNA-seq dataset, and Moto-miN vs. miN (logFC >2.5 and p 
<.05) in the microarray dataset - were assessed for significant contingency using a one-tailed 
Fisher's exact test.   
Quantitative PCR 
Total RNA was extracted using TRIzol (Invitrogen, USA) according to the 
manufacturer's instruction. Reverse-transcribed complementary DNA (cDNA) was synthesized 
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from 500ng of RNA with SuperScript III First-Strand Synthesis SuperMix (Invitrogen, USA) or 
from 10 ng of RNA for microRNAs expression analyses using specific stem-loop primer probes 
from TaqMan MicroRNA Assays (Invitrogen, USA). Subsequently, the cDNA was analyzed on 
a StepOnePlus Real-Time PCR System (AB Applied Biosystems, Germany). Expression data 
were normalized to housekeeping genes HPRT1 and RNU44 for coding genes and microRNAs, 
respectively, and analyzed using the 2-ΔΔCT relative quantification method. The following primers 
were utilized: 
miRNA qRT-PCR primers 
hsa-miR-218 (Thermo Fisher Cat. # 4427975) 
RNU-44 (Thermo Fisher Cat. # 4427975) 
For primers utilized for mRNA qRT PCR see Table S2. 
Overlap with ISL1/LHX3 ChIP Seq 
To identify the genes regulated by LHX3 and ISL1 in motor neurons, ISL1- and LHX3-
ChIP sequencing data (Mazzoni et al., 2013) were used. We selected the regions co-occupied by 
ISL and LHX3 during ES to motor neuron differentiation, accounting for 84.2% of peak regions 
called in each ChIP-seq data. Based on the peaks co-occupied by ISL1 and LHX3, we annotated 
3,486 closest genes with peaks located within 5Kb upstream of TSS and intragenic regions. 
Comparing those annotated genes with genes selectively enriched in Moto-miNs vs miNs (log2 
fold change=>2.5, p<0.01), identified 323 genes co-occupied by ISL1 and LHX3 that are also 
upregulated when miR-9/9*-124 is co-expressed with ISL1/LHX3.  
Data Availability 
The RNA-seq, ATAC-seq, MeDIP and MRE-seq, and microarray data generated in this study 
are: 14 samples, single-ended RNA-seq libraries from starting fibroblasts and miNs throughout 
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direct conversion (Days 3, 6 ,10, 20 and 30), 2 replicates per timepoint; 10 pair-ended ATAC-
seq libraries from day 10 Ctrl, day 10 and day 20 miNs, day 20 miNs with shBRG1 and day 20 
miNs with an shCtrl, 2 replicates for each timepoint; 6 microarrays from starting fibroblasts, day 
35 miNs, and day 35 moto-miNs, 2 replicates per condition; 6 samples of pair-ended MeDIP 
libraries and 6 samples of MRE single-ended libraries from day 10, 20, 30 miNs and 
corresponding  Ctrls. The accession number for the RNA-seq, ATAC-seq, MeDIP and MRE-seq, 
and microarray data data reported in this paper is currently being processed and will be 
available in the paper cited at the beginning of this chapter. The accession number for the 
TRAP-seq data is GEO:GSE93412. 
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Chapter 4: Conclusions and Future 
Directions 
Significance 
 One of the greatest barriers in the study and treatment of neuronal disorders and 
neurodegenerative diseases has been a lack of patient-specific neuronal subtypes that retain their 
age-associated phenotypes. The desire to procure these cells stems from the observation that 
many of these neuronal diseases are uniquely human and may require a cellular platform that is 
truly representative of the affected species. My thesis has been aimed at meeting this goal 
through miRNA-mediated direct conversion technology. While examples of this conversion 
modality had been demonstrated at and near the onset of this thesis, that is, the generation of 
cortical neurons (Yoo et al., 2011) and of medium spiny neurons (Victor et al., 2014), the general 
applicability of this reprogramming paradigm and it’s molecular underpinnings remained 
unknown. To this end, I set out to determine whether miRNAs alone, i.e. in the absence of 
transcription factors, were capable of trans-differentiating human fibroblasts into functional 
neurons. Surprisingly, I found the cellular activities of miR-9/9* and miR-124 were sufficient to 
elicit direct neuronal conversion of adult human fibroblasts. More surprisingly, while probing the 
identity of converted neurons using gene expression profiling, I discovered these miRNA-
induced neurons (miNs) do not possess neuronal subtype identity, suggesting that the activities 
of subtype-specific transcription factors utilized in previous studies requires a permissive 
environment brought about by the ectopic expression of miR-9/9*-124.  
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 Exploring this permissive state provided molecular insight into the phenomena of direct 
conversion and cell-fate acquisition. In particular, the observation that many neuronal loci 
encoding genes important in diverse subtypes open during direct conversion by miR-9/9*-124 
but are not expressed provided an epigenetic blueprint for generating other clinically relevant 
neuronal subtypes. The further derivation of motor neurons, highlighted in chapter 3, explores 
this hypothesis and opens the door to generating other neuronal subtypes. 
 Altogether, the significance of this work can be separated into two broad findings. First, 
despite the short sequence length of miRNAs, they are capable of carrying enough regulatory 
information to reprogram cellular identity at epigenetic, transcriptomic, and functional levels. 
This is a significant finding as the predominant view of miRNAs revolves around the notion of 
“fine-tuning” gene expression. My findings provide a counterpoint to this hypothesis, suggesting 
that miRNAs are indeed capable of radically altering gene expression.  
 The second significant finding, the ectopic expression of miR-9/9*-124 and the motor 
neuron transcription factors, ISL1 and LHX3, is sufficient to directly convert adult human 
fibroblasts from young and old individuals into motor neurons, provides a platform for motor 
neuron disease modeling.  
 
Future Directions 
What targets of miR-9/9*-124 are responsible for chromatin remodeling?  
 To date, miRNAs have not been shown to directly alter local chromatin structure. Thus, 
our current understanding of miRNA biology suggests that miR-9/9* and miR-124 likely repress 
the expression of chromatin remodeling genes. Indeed, during neuronal development miR-9* and 
miR-124 repress the expression of the chromatin regulating BAF-complex subunit, BAF53a. 
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This allows for the replacement of BAF53a with BAF53b as neuronal progenitors differentiate 
(Yoo et al., 2009). This switch is also observed during miRNA-mediated direct conversion 
(unpublished data). However, preventing this switch by overexpressing BAF53A during 
conversion does not inhibit neuronal conversion of fibroblasts. Therefore other chromatin 
remodeling genes likely play a role in the epigenetic changes observed during conversion. These 
genes may not be direct targets of miR-9/9*-124, but may be part of a regulatory cascade 
initiated by miR-9/9*-124 overexpression. To identify direct targets of miR-9/9*-124 a technique 
such as HITS-CLIP followed by high throughout sequencing could be employed. Coupled with 
RNA-SEQ, these two techniques would generate predicted miRNA-mRNA binding and 
correlative gene expression changes. To confirm predicted miRNA-target interactions a 
luciferase essay could be employed consisting of a luciferase-target-3’UTR fusion that is co-
transfected with the predicted miRNA binding partner. Decreases in luciferase activity compared 
to a non-target control 3’UTR would validate an interaction between predicted miRNAs and 
their targets. To further demonstrate binding the target sequence within the 3’UTR should be 
mutated. If this restores luciferase activity it can be inferred that the miRNA of interest binds. 
 The gene expression studies described in chapter two of this thesis revealed widespread 
changes in genes responsible for diverse epigenetic regulatory programs. Many of these genes 
are not predicted to be targets of miR-9/9* or miR-124 suggesting their expression changes are 
the results of secondary or greater events downstream of these miRNAs. Nonetheless, their role 
in reprogramming could be systematically addressed using overexpression and knockdown 
studies. For example, I knocked down the expression of BRG1, the catalytic unit of the BAF 
chromatin remodeling complex, and performed both ICC and ATAC-seq to test the role of 
chromatin remodeling in conversion. Using a scheme such as this, it would be interesting to test 
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the individual roles of DNA-methylation writers and readers, histone proteins, histone modifiers, 
and chromatin remodeling genes whose expression changes during conversion. Paring down the 
list of differentially expressed epigenetic modifiers would represent a key step in understanding 
the contribution of each component in reprogramming and would begin to define pathways 
required for cell fate conversion. Ultimately, uncovering the genes that create or remove barriers 
in reprogramming may offer avenues for increasing the speed and efficiency of direct cell fate 
conversion. 
Guiding Conversion to other Clinically Relevant Neuronal Subtypes.  
 Chromatin profiling by ATAC-seq revealed the opening of key subtype-specific loci in 
response to miR-9/9*-124 expression. Specifically, dopaminergic neuron markers (TH and 
SLC6A3), serotonergic neuron markers (FEV, LMX1B and SLC6A4), GABAergic neuron 
markers (SLC6A1, SLC32A1, GAD2), striatal medium spiny neuron marker (PPP1R1B), 
glutamatergic neuron markers (GLUL and SLC1A6), and cholinergic or motor neuron markers 
(MNX1, CHAT, and SLC5A7) opened but were not expressed. To date, three neuronal subtypes 
have been derived using miRNA-mediated direct conversion therefore the probability of 
generating neuronal subtypes marked by regions that open in response to miR-9/9*-124 is high. 
Towards this goal, I have cloned genes important in the development and specification of 
dopaminergic neurons into lentiviral vectors, for example, NURR1, IRX3, OTX2, and LMX1A. 
These genes will be expressed individually and in combination with one another in the 
background of miR-9/9*-124 and assayed for their ability to activate key dopaminergic markers 
such as TH. The acquisition of the dopaminergic fate will be further determined through gene 
expression and functional studies. As dopaminergic neurons are the major neuronal subtype 
affected in Parkinson’s Disease (PD), the ability generate these cells from patients may provide 
a valuable tool in the study of PD. Additionally, establishing multiple cultures of Dopaminergic 
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neurons from multiples patients with pathological PD may provide a powerful cellular platform 
for drug screening. The output of such a screen would be the production of dopamine.  
Does Trans-differentiation Transit Through Analog or Digital Cellular States? 
 Our time-course RNA and ATAC-seq studies revealed steady increases and decreases of 
signal intensity over time suggesting cell fate conversion occurs gradually until terminal 
neuronal identity has been acquired. However, at the time these experiments were conducted 
only entire populations of cells could be analyzed. RNA-seq in particular required approximately 
200,000 cells per condition to yield sufficient quantities of RNA for sequencing. Thus, an 
alternative hypothesis that would explain the data is: direct conversion consists of multiple 
binary cell fate switches that occur over time non-synchronously towards a final neuronal 
identity. Such events would be masked at the population level. To determine whether trans-
differentiation is binary or digital, single-cell RNA-seq could be employed at multiple timepoints 
during conversion. In collaboration with Dr. Samantha Morris at Washington University in St. 
Louis, we have begun working towards this goal. To begin, I collected 10,000 miNs and Moto-
miNs at 5, 10 15, 20 and 30 days into reprogramming in addition to starting adult human 
fibroblasts. After all samples were collected and slowly frozen they were transferred to the 
Morris Lab where single-cell libraries were generated. At the time of writing these cells are in 
the process of being sequenced. To date, little is known about direct neuronal cell-fate 
conversion at the single cell level and the results of this experiment may reveal more definitive 
insights into the dynamics of direct cell-fate conversion by removing the mask of population 
effects. Further, specific genes that associate with early or failed commitment to the neuronal 
fate may constitute accelerants or barriers to the conversion process, respectively. Exploring the 
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roles of these genes further in conversion through activation or inhibition studies may provide 
methods to increase the efficiency and speed of conversion. 
Can Local Cues Guide Subtype Acquisition? 
 All of our efforts have been aimed at identifying transcription factors capable of guiding 
neuronal conversion. The rationale behind this approach is that it is consistent and does not 
require complex growth media changes where cocktails of patterning molecules are added at 
defined timepoints. However this approach is also limiting in that it relies on known 
developmental pathways. It remains unknown if miNs can be terminally differentiated in vivo 
using local patterning cues provided by the developing neuroectoderm. By transplanting 
fibroblasts into different regions of the developing mouse brain we could simultaneously test the 
plasticity of the miRNA-induced neuronal state and identify spatio-temporal cues important in 
the establishment of neuronal subtypes. Two different approaches could be used to explore this 
question. First, 30 days after injecting miNs into defined regions, mouse brains could be 
harvested, sectioned and stained for human specific proteins, subtype specific markers, pan-
neuronal markers, and fibroblast specific proteins. The combination of overlaps between these 
markers would reveal if conversion occurred and if subtype identity was acquired. 
 
Can miRNAs illicit in vivo reprogramming? 
After optimizing the stereotaxic injection technique, the possibility of converting non-
neuronal cells to neurons in vivo could also be examined. The development of such in vivo 
reprogramming techniques could provide a therapeutic intervention for neuronal trauma or 
disease. The ideal cell to reprogram would be resident astrocytes due to their location and 
 93 
tendency to proliferate upon injury. To determine if trans-differentiation occurs, lineage tracing 
could be employed whereby a GFAP-Cre mouse line is crossed with a mouse strain that contains 
a LoxP flanked STOP codon preceding RFP at the ROSA26 locus. Progeny containing both the 
GFAP-Cre and LoxP-STOP-LoxP-RFP alleles would also contain RFP-positive astrocytes. 
These mice would then be injected with a GFP-miR-9/9*-124 containing lentivirus at different 
locations in the brain. After 2, 4 and 8 weeks mice would be sacrificed and their brains processed 
for ICC. Cells that were transduced with the miRNA-containing construct would be identified by 
GFP fluorescence. Transduction of astrocytes would be ascertained by presence of GFP and RFP 
fluorescence. Co-staining with neuronal markers such as MAP2 or TUJ1 would test whether 
GFP/RFP double positive cells converted into neurons. Obtaining proof of principle experiments 
using miRNAs would open the gateway to guiding in vivo reprogramming of astrocytes to 
defined neuronal subtypes through the addition of transcription factors.  
 
Evaluate the capability of reprogrammed motor neurons to function properly in vivo  
If reprogrammed cells are to be used for regenerative therapies they must be able to 
function correctly in vivo. In particular, functional recovery mediated by cell replacement 
strategies requires that transplanted cells both survive and restore lost connectivity. Several 
studies have demonstrated efficient engraftment and functional recovery when using ES and iPS 
derived neural progenitors in rat and mouse models of SCI (Lu et al., 2014a). The ability of ex 
vivo derived post-mitotic neurons to integrate into the mammalian spinal cord has not been 
explored. By supplying all of the required information for conversion genetically, our 
reprogramming scheme may be well-suited for delivery of motor neurons, and motor neurons 
alone, to sites of injury. Testing this hypothesis would require transplanting moto-miNs into the 
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spinal cord of immunodeficient mice at 1, 2, 3, and 4 weeks post-transduction to ascertain the 
most favorable timepoint for effective survival.  After determining the time of transplantation 
that yields the highest amount of neuronal engraftment I would test if transplanted cells can 
integrate into the local circuitry by recording from spinal cord slices. 
 Upon verifying that induced neurons are capable of engrafting into the murine spinal 
cord, I would transplant cells into a mouse model of spinal cord injury. Spinal cord injury could 
be induced by a dorsal hemisection of the spinal cord in immunodeficient mice, an injury model 
that generates stereotyped locomotor deficits such as impaired paw placement during walking 
(Zorner et al., 2010). This phenotype has the potential to be rescued by cell transplantation and is 
less debilitating than other models of spinal cord injury (Zorner et al., 2010). I would then 
examine the extent of cell survival, axon outgrowth, myelination by the host and formation of 
synaptic structures 2 and 4 weeks post transplantation. Functional recovery could be assessed by 
a battery of locomotor tests and compared to results obtained from controls injected with post-
mitotic fibroblasts and mock injections. 
  Approaches in transplanting neural progenitors into the mammalian nervous system have 
been met with mixed success (Lu et al., 2014a). Recently, the injection of cells contained within 
biomaterial scaffolds and supplemented with neurotrophic factors showed greatly enhanced 
survival and growth of transplanted cells (Lu et al., 2014a; Lu et al., 2014b). If poor survival 
and/or engraftment of transplanted cells is observed, the use of biomaterial scaffolds and growth 
factor supplementation to cell suspensions during injection may need to be explored. Restoring 
locomotor activity requires functional integration into the site of injury and surrounding circuit 
therefore, if the environment created by dorsal hemisection is too hostile for transplantation, or 
the injury too severe, additional models of spinal cord injury may need to be utilized. 
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Elucidate the mechanism of guiding reprogramming into motor neurons. 
The process by which a fully differentiated fibroblast of mesodermal origin is directly 
converted into a functional motor neuron – a highly specialized cell normally arising from 
neuroectoderm - remains largely enigmatic. Exploring the etiology of cell fate conversion 
presents a unique opportunity in the study of lineage commitment. Simultaneously, 
understanding the molecular pathways activated during neural conversion is necessary for the 
interpretation of experiments utilizing reprogrammed cells. In addition to determining the 
manner in which transcription factors guide reprogramming towards motor neurons, identifying 
the logic and function of pro-neural transcription factors within the neurogenic state primed by 
miR-9/9*-124 may provide a molecular foundation for choosing transcription factors that may 
guide conversion towards additional clinically relevant neural subtypes.  
 To understand how miR-9/9*-124 and ISL1 and LHX3 are able to reprogram human 
fibroblasts into motor neurons, I would conduct a series of ChIP-Seq experiments to determine if 
genome binding requires miRNAs and determine the binding locations of each TF. From these 
data, I will examine the association of transcription factors with genes important in neurogenesis 
and motor neuron development. To explore the possibility that transcription factors are 
cooperating with one another, I would ask if transcription factors co-occupy distinct sites. Direct 
associations between reprogramming factors could then be tested using Co-IP assays. The 
relative contribution of endogenous and exogenous transcription factors within complexes may 
be resolved through the use of tagged exogenous genes. I have generated FLAG-HA tagged 
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versions of both LHX3 and ISL1 and shown they do not interfere with motor neuron fate 
acquisition.  
 The molecular underpinnings of direct conversion remain largely unexplored. This set of 
experiments is designed to gain insights into DNA accessibility, the activation of defined genetic 
networks, and the role of transcription factor cooperation in miRNA-mediated reprogramming. 
Since little is known about each of these processes in the context of cell fate conversion, these 
experiments could shed light on how one cell type is able to change into another without going 
through a pluripotent intermediate. 
 
Impact and Closing Remarks 
 During the course of this dissertation I was able to induce and characterize a miRNA-
induced neurogenic state in adult human fibroblasts. The insights provided through this in depth 
characterization are critical to further reprogramming efforts in the laboratory and clinic. This 
notion is exemplified by the generation of motor neurons directly from adult human fibroblasts. 
By further exploring the neurogenic ground state elicited by miRNAs alone, an epigenetic basis 
for subtype-specification emerged. Pursuing the hypothesis that miRNAs open the neurogenic 
potential of fibroblasts by enabling access to TF binding sites necessary for neuronal subtype 
development, led to the derivation of functional motor neurons directly from adult human 
fibroblasts.  
 The impact of this work revolves around the pioneering activities of miR-9/9*-124. 
Before this work, it was broadly accepted that miRNAs only “fine tune gene expression.” 
Contrary to this idea, I have shown that despite their short sequence length, miRNAs contain 
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enough genetic information to radically reprogram the epigenome and transciptome. These 
activities lead to the generation of functional neurons, a property that I exploited to derive a 
clinically relevant neuronal subtype. Going forward, the method of generating motor neurons 
directly from adult human fibroblasts described within this thesis may pave the way to a greater 
understanding of motor neuron diseases such as ALS and SMA. Further, the epigenetic blueprint 
formed by miRNA overexpression that revealed by ATAC-seq could lead to the generation of 
additional neuronal subtypes.  
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Supplemental Table 1, Key Resources Table 
REAGENT or 
RESOURCE 
SOURCE IDENTIFIER 
Antibodies 
Mouse monoclonal 
anti-MAP2 
Sigma-Aldrich 
 
Cat# M4403; RRID: AB_477193 
Rabbit polyclonal anti-
TUBB3B 
Covance Research 
Products Inc 
Cat# PRB-435P-100; RRID: AB_291637 
Chicken polyclonal 
anti- NeuN 
Aves Labs Cat# NUN, RRID:AB_2313556 
Mouse monoclonal 
anti-SCN1A 
Sigma-Aldrich 
 
Cat# S8809, RRID:AB_477552 
Mouse monoclonal 
anti-ANKG 
UC Davis/NIH 
NeuroMab Facility 
Cat# 73-146, RRID:AB_10697718 
Mouse monoclonal 
anti-SV2 
DSHB Cat# SV2, RRID:AB_2315386 
Mouse monoclonal 
anti-MNX1 
DSHB Cat# 81.5C10, RRID:AB_2145209 
Goat polyclonal anti-
CHAT 
Millipore Cat# AB144P, RRID:AB_2079751 
Mouse monoclonal 
anti-SMI-32 
BioLegend Cat# 801701, RRID:AB_2564642 
Rabbit polyclonal anti-
Ki-67 
Abcam Cat# ab15580, RRID:AB_443209 
Mouse monoclonal 
anti-Myosin 
DSHB Cat# A4.1025, RRID:AB_528356 
Mouse monoclonal 
anti-NCAM 
Santa Cruz 
Biotechnology 
Cat# sc-106, RRID:AB_627128 
Mouse monoclonal 
anti-5-Methylcytidine 
Eurogentec Cat# BI-MECY-0100, RRID:AB_2616058 
Rabbit polyclonal anti-
Mouse IgG 
Jackson 
ImmunoResearch 
Labs 
Cat# 315-001-003, RRID:AB_2340031 
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Monoclonal anti-EGFP Memorial Sloan-
Kettering 
Monoclonal 
Antibody Facility 
Clone 19C8 
Monoclonal anti-EGFP Memorial Sloan-
Kettering 
Monoclonal 
Antibody Facility 
Clone 19F7 
Chemicals, Peptides, and Recombinant Proteins 
Fetal bovine serum 
(FBS), qualified, US 
Department of 
Agriculture (USDA)-
approved regions 
Life Technologies Cat# 10437028 
Polybrene Sigma-Aldrich Cat# H9268 
Neuronal Media ScienCell 
Research 
Laboratories 
Cat# 1521 
Doxycycline hyclate 
(Dox)  
Sigma-Aldrich Cat# D9891 
Poly-L-ornithine 
solution 
Sigma-Aldrich Cat # P4957 
Laminin Sigma-Aldrich Cat# L2020 
Fibronectin,  Sigma-Aldrich Cat# F4759 
Valproic acid (VPA), 
sodium salt,  
Sigma-Aldrich Cat# 676380 
Dibutyryl-cAMP 
sodium salt,  
Sigma-Aldrich Cat# D0627 
Retinoic acid (RA) Sigma-Aldrich Cat# R2625 
Pierce Protein A/G 
Agarose 
ThermoFisher 
Scientific 
Cat# 20421 
Ampure XP beads Ampure Cat# A63880 
 
Critical Commercial Assays  
RNeasy plus micro kit Qiagen Cat# 74034 
SMARTer Ultra Low 
RNA Kit for Illumina 
sequencing 
Clontech Cat# 635029 
Illumina Genomic DNA 
Sample Prep Kit 
Illumina  
Illumina TotalPrep 
kit 
ThermoFisher 
Scientific 
Cat# AMIL1791 
Whole Human 
Genome Microarray 
Kit, 4x44K 
Agilent 
Technologies 
Cat# G4112F 
QIAquick PCR 
Purification Kit 
Qiagen Cat# 28104 
MinElute Gel 
Extraction Kit 
Qiagen Cat# 28604 
RNeasy Mini Kit Qiagen Cat# 74104 
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Nugen Amplification 
Kit Ovation® RNA‐Seq 
System V2 
NuGEN Cat# 7102 
Deposited Data  
   
   
   
Experimental Models: Mice  
Tg(Chat-
EGFP/Rpl10a)DW167
Htz 
PMID: 19013282 N/A 
Tg(Snap25-
EGFP/Rpl10a)JD362J
dd 
PMID: 22865458 N/A 
Experimental Models: Cell Lines 
Primary 22 year old 
human adult 
fibroblasts 
NIGMS Human 
Genetic Cell 
Repository at the 
Coriell Institute for 
Medical Research 
GM02171 
Primary 42 year old 
human adult 
fibroblasts 
Washington 
University in St. 
Louis School of 
Medicine iPSC 
core facility 
F09-238 
Primary 56 year old 
human adult 
fibroblasts 
NIA Aging Cell 
Repository at the 
Coriell Institute for 
Medical Research 
AG04148 
Primary 68 year old 
human adult 
fibroblasts 
NINDS Cell Line 
Repository at the 
Coriell Institute for 
Medical Research 
ND34769 
Primary neonatal 
human dermal 
fibroblasts 
ATCC PCS-201-010 
Lenti-X 293LE cell line Clontech Cat# 632180 
Human skeletal 
myoblasts (HSMM) 
Lonza Cat# CC-2580 
Recombinant DNA 
N174 Addgene 60859 
N106 Addgene 66808 
pMD2.G Addgene 12259 
psPAX2 Addgene 12260 
pT-BCL-9/9*-124 Addgene 60859 
pT-BCL-NS (Victor et al., 2014) N/A 
LHX3-N174 This paper  
ISL1-N174  This paper  
pLKO-shBRG1 This Paper  
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pLKO shEGFP This Paper  
synEGFP (Victor et al., 2014) N/A 
Software and Algorithms 
pCLAMP 10 Software Molecular Devices https://www.moleculardevices.com/systems/conventional
-patch-clamp/pclamp-10-software 
Graphpad Prism 7 
 
GraphPad 
Software Inc 
http://www.graphpad.com/ 
 
edgeR 3.4 (Robinson et al., 
2010) 
https://bioconductor.org/packages/release/bioc/html/edg
eR.html 
limma (Ritchie et al., 
2015) 
https://bioconductor.org/packages/release/bioc/html/limm
a.html 
 
Metascape (Tripathi et al., 
2015) 
http://metascape.org/gp/index.html#/main/step1 
methylQA N/A http://methylqa.sourceforge.net/ 
M&M statistical model (Zhang et al., 
2013) 
http://epigenome.wustl.edu/MnM/methylMnM.pdf 
GREAT package (McLean et al., 
2010) 
http://bejerano.stanford.edu/great/public/html/ 
HOMER software (Heinz et al., 2010) http://homer.salk.edu 
TrimGalore, version 
0.4.2 
Felix Krueger, 
Babraham 
Bioinformatics 
http://www.bioinformatics.babraham.ac.uk/projects/t
rim_galore/ 
bowtie2 (Langmead and 
Salzberg, 2012) 
http://bowtie-
bio.sourceforge.net/bowtie2/index.shtml 
Picard Tools Broad Institute 
 
https://broadinstitute.github.io/picard/ 
HTSeq count (Anders et al., 
2015) 
http://www-
huber.embl.de/users/anders/HTSeq/doc/overview.h
tml 
CEAS software (Shin et al., 2009) http://liulab.dfci.harvard.edu/CEAS/ 
STAR (Dobin et al., 2013) https://github.com/alexdobin/STAR 
DREM (Schulz et al., 
2012) 
http://www.sb.cs.cmu.edu/drem/ 
cDREM (Wise and Bar-
Joseph, 2015) 
http://sb.cs.cmu.edu/cdrem/ 
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Supplemental Table 2, Primer sequences  
used for qRT PCR analysis  
 
Primer 
Name Sequence (5'-3') 
S100A4 
FWD GATGAGCAACTTGGACAGCAA 
S100A4 
REV CTGGGCTGCTTATCTGGGAAG 
VIM FWD AGTCCACTGAGTACCGGAGAC 
VIM REV CATTTCACGCATCTGGCGTTC 
COL13A1 
FWD GGAGACGGCTATTTTGGGACG 
COL13A1 
REV TCCTTGAGTGGAGCTTCCATT 
ChAT FWD TCAATCATGTCCAGCGAGTC 
ChAT REV AACGAGGACGAGCGTTTG 
HB9 FWD CTCCTACTCGTACCCGCAG 
HB9 REV TTGAAGTCGGGCATCTTAGGC 
SLC18A3 
FWD TTCGCCTCTACAGTCCTGTTC 
SLC18A3 
REV GCTCCTCCGGGTACTTATCG 
HOXB4 
FWD CGTGAGCACGGTAAACCCC 
HOXB4 
REV CGAGCGGATCTTGGTGTTG 
HOXC6 
FWD ACAGACCTCAATCGCTCAGGA 
HOXC6 
REV AGGGGTAAATCTGGATACTGGC 
HOXA7 
FWD CGTTCCGGGCTTATACAATGT 
HOXA7 
REV CTCGTCCGTCTTGTCGCAG 
HOXB7 
FWD TTCCCAGAACAAACTTCTTGTGC 
HOXB7 
REV GCATGTTGAAGGAACTCGGCT 
HOXC8 
FWD ACCGGCCTATTACGACTGC 
HOXC8 
REV TGCTGGTAGCCTGAGTTGGA 
HOXD8 
FWD GGAAGACAAACCTACAGTCGC 
HOXD8 
REV TCCTGGTCAGATAGGGGTTAAAA 
HOXA9 
FWD TACGTGGACTCGTTCCTGCT 
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HOXA9 
REV CGTCGCCTTGGACTGGAAG 
HOXC9 
FWD ACTCGCTCATCTCTCACGACA 
HOXC9 
REV GACGGAAAATCGCTACAGTCC 
HOXD9 
FWD GGACTCGCTTATAGGCCATGA 
HOXD9 
REV GCAAAACTACACGAGGCGAA 
HOXC10 
FWD ACATGCCCTCGCAATGTAACT 
HOXC10 
REV GAGAGGTAGGACGGATAGGTG 
HOXC11 
FWD ATGTTTAACTCGGTCAACCTGG 
HOXC11 
REV GCATGTAGTAAGTGCAACTGGG 
HOXD11 
FWD TCTCCGAGTCCTCGTGGGGA 
HOXD11 
REV GCAAAACACCAGCGCCTTCTA 
HPRT FWD TCCTTGGTCAGGCAGTATAATCC 
HPRT REV GTCAAGGGCATATCCTACAACAAA 
 
 
 
 
 
 
 
 
 
 
 
